Skip to main content
Science Advances logoLink to Science Advances
. 2021 Sep 10;7(37):eabj2101. doi: 10.1126/sciadv.abj2101

Neutrophil extracellular traps enhance macrophage killing of bacterial pathogens

Andrew J Monteith 1, Jeanette M Miller 1, C Noel Maxwell 2,3, Walter J Chazin 2,3,4,5, Eric P Skaar 1,5,*
PMCID: PMC8442908  PMID: 34516771

S100A9 regulates mitochondrial-mediated neutrophil extracellular trap formation, which augments macrophage bactericidal activity.

Abstract

Neutrophils and macrophages are critical to the innate immune response, but cooperative mechanisms used by these cells to combat extracellular pathogens are not well understood. This study reveals that S100A9-deficient neutrophils produce higher levels of mitochondrial superoxide in response to Staphylococcus aureus and, as a result, form neutrophil extracellular traps (suicidal NETosis). Increased suicidal NETosis does not improve neutrophil killing of S. aureus in isolation but augments macrophage killing. NET formation enhances antibacterial activity by increasing phagocytosis by macrophages and by transferring neutrophil-specific antimicrobial peptides to them. Similar results were observed in response to other phylogenetically distinct bacterial pathogens including Streptococcus pneumoniae and Pseudomonas aeruginosa, implicating this as an immune defense mechanism that broadly enhances antibacterial activity. These results demonstrate that achieving maximal bactericidal activity through NET formation requires macrophages and that accelerated and more robust suicidal NETosis makes neutrophils adept at increasing antibacterial activity, especially when A9 deficient.

INTRODUCTION

Staphylococcus aureus is a Gram-positive bacterium that causes a wide range of infections and is the leading cause of bacterial endocarditis (1) and second most frequent agent of bloodstream infections (2). Professional phagocytes, such as neutrophils and macrophages (Mφs), have an arsenal of antimicrobial processes that are critical to combating bacterial pathogens. During infection, phagocytosis of S. aureus by neutrophils initiates bacterial killing through the production of reactive oxygen species (ROS) by NADPH (nicotinamide adenine dinucleotide phosphate) oxidase (35) or fusing granules containing antimicrobial peptides (AMPs) to the phagosome (6, 7). In addition, neutrophils combat extracellular pathogens by secreting neutrophil extracellular traps (NETs) consisting of DNA studded with AMPs through a process termed “NETosis.” Within 5 to 60 min of engaging S. aureus, vital NETosis results in the exocytosis of NETs leaving the membrane intact (8), while suicidal NETosis, which occurs after 2 to 4 hours, causes rupture of the cell membrane through the terminal release of NETs (9). S. aureus induces NETosis, but the antibacterial activity of NETs varies depending on the context, where NET formation is beneficial to the host during pneumonia (10) and systemic infections (11) but detrimental in combating biofilms (12). However, in vitro, the biological function of NETs in response to bacterial pathogens has only been assessed in isolation with neutrophils being the only cell type present, which does not reflect the full cellular complexity of the host-pathogen interface.

Calprotectin, a heterodimer formed by the S100A8 and S100A9 proteins (13, 14), is enriched within neutrophils comprising approximately 50% of the cytoplasmic protein (15). During inflammation, calprotectin sequesters transition metals from pathogens (16, 17) and influences immune cell function as a chemoattractant (18, 19) and damage-associated molecular pattern (DAMP) (20, 21). In addition, S100A9-deficient (A9−/−) mice, which lack calprotectin, exhibit increased S. aureus burdens in the kidney and liver (16, 17) but lower burdens in the heart with increased survival (22) when systemically infected. This indicates that S100A9 may have alternative functions in regulating the immune response in an organ-specific manner.

Mφs are also critical to the innate immune response to S. aureus (23, 24) and elicit most of their antimicrobial activity after internalizing the pathogen. Following phagocytosis, Mφs generate ROS and reactive nitrogen species (25, 26), mobilize transition metals (27, 28), and acidify the phagosome to activate hydrolytic enzymes (29, 30) in an effort to intoxicate pathogens. Despite these antimicrobial functions, Mφs are not effective at eradicating internalized S. aureus in isolation (23, 31, 32).

Neutrophils can synergistically enhance the antibacterial function of Mφs. Phagocytosis of infected apoptotic neutrophils allows Mφs to acquire functionally active myeloperoxidase (MPO), lactoferrin, and defensins from neutrophil granules, thereby enhancing antimicrobial activity (3336); however, this phenomenon has only been observed in response to intracellular bacterial pathogens. During staphylococcal infection, both neutrophils (37, 38) and Mφs (3942) aid in the formation and maintenance of abscesses, putting these cells in close proximity. Yet, most host-pathogen interactions studies involving S. aureus have been assessed using isolated immune cells or whole blood lacking mature Mφs. Defining how neutrophils and Mφs cooperatively combat S. aureus will help define an effective innate immune response to S. aureus and to provide insight into antibacterial strategies that could be broadly applied to other extracellular bacterial pathogens.

Here, we show that A9−/− neutrophils produce higher levels of mitochondrial superoxide (O2) in response to S. aureus, causing accelerated and robust suicidal NETosis and attenuated primary degranulation. This establishes intracellular S100A9 as a critical molecular rheostat in neutrophil function. Increased suicidal NETosis does not provide an advantage in neutrophil-mediated killing of bacterial pathogens in isolation but rather augments Mφ killing in response to multiple phylogenetically distinct pathogens, including S. aureus, Streptococcus pneumoniae, and Pseudomonas aeruginosa. NET formation increases the antibacterial activity of Mφs by facilitating their phagocytosis of bacteria and by transferring biologically active neutrophil-specific AMPs to Mφs. By using A9−/− neutrophils as a tool to assess NET-related biology, these results demonstrate that NET formation acts as a conduit for neutrophils to enhance the antibacterial activity of Mφs. Furthermore, neutrophils with accelerated and more robust suicidal NETosis, such as A9−/−, are more adept at increasing the antibacterial activity of Mφs against multiple bacterial pathogens.

RESULTS

A9−/− mice have increased protection from methicillin-resistant S. aureus

Previous systemic infections of A9−/− mice used the S. aureus strain Newman (16, 17, 22), which has been laboratory adapted over many decades (43), and may differ in virulence compared to recent clinical isolates. A9−/− mice systemically infected with the methicillin-resistant S. aureus (MRSA) strain USA300 (LAC) showed reduced mortality (Fig. 1A), despite similar weight loss (fig. S1A). In addition, decreased bacterial burdens were observed specifically in the heart 4 days postinfection (dpi) compared to C57BL/6J wild-type (WT) mice (Fig. 1B). While these results were similar to what was obtained using Newman (22), they did not fully recapitulate every phenotype in the A9−/− mice (16, 17), as bacterial burdens in WT and A9−/− mice were comparable in the kidney and liver (Fig. 1B). These discrepancies are likely strain specific, as differences in pathology between Newman and USA300 have been described during systemic infection (44). Despite these differences, A9−/− mice are protected from USA300-mediated lethality and heart colonization by MRSA.

Fig. 1. A9−/− mice are more protected from systemic MRSA infection.

Fig. 1.

Mice were systemically infected (inf.) with USA300 [colony-forming units (CFU) = 2 × 107]. (A) During the infection, mouse survival was monitored. Each point represents the percentage of living mice (mock, n = 14, WT; inf., n = 31, A9−/−; inf., n = 29). (B) At 4 dpi, organs were homogenized and CFU was counted using spot plating [limit of detection (LoD)]. Each point represents a single mouse (mock, n = 11) (WT; inf., n = 13) (A9−/−; inf., n = 16). (A) Log-rank (Mantel-Cox) test or (B) two-way analysis of variance (ANOVA) with Tukey multiple comparisons test (**P ≤ 0.01 and ****P ≤ 0.0001; ns, not significant).

S100A9 deficiency enhances suicidal NETosis

Neutrophils use multiple antimicrobial processes when engaging S. aureus. To test the impact of S100A9 on these processes, neutrophil function was assessed by flow cytometry (gating scheme provided in fig. S1B). Upon engaging S. aureus, neutrophils couple phagocytosis with the respiratory burst (35). Phagocytosis of fluorescently labeled S. aureus by WT and A9−/− neutrophils was comparable (fig. S1C). Despite equal phagocytosis, the generation of ROS, as measured by dihydrorhodamine 123 (DHR123) staining, was increased in A9−/− neutrophils relative to WT when stimulated with S. aureus (fig. S1D). However, this phenotype was not present in vivo as neutrophils isolated from the tissues of infected WT and A9−/− mice produced comparable levels of ROS when stained with DHR123 ex vivo (fig. S1E). These results suggest that increased ROS production does not account for the protection of A9−/− mice during infection.

Neutrophils release granules containing AMPs in response to S. aureus (6, 7). To quantify degranulation, neutrophils were stimulated with S. aureus, and the abundance of CD63 (primary degranulation) and CD35 (secretory degranulation) on the surface of the cell was quantified by flow cytometry. When cultured with S. aureus, primary degranulation was reduced in A9−/− neutrophils compared to WT after 120 min (Fig. 2A and fig. S1F). Not all degranulation was restricted in A9−/− neutrophils, as secretory degranulation was comparable to WT (fig. S1G). Furthermore, consistent with in vitro observations, primary degranulation by neutrophils was decreased in the heart and liver but comparable in the kidney of A9−/− mice relative to WT mice, 4 dpi (Fig. 2B and fig. S1H). These results indicate that primary degranulation is impaired in A9−/− neutrophils responding to S. aureus and that reduced primary degranulation in the heart coincides with reduced bacterial burdens (Fig. 1B).

Fig. 2. A9−/− neutrophils have accelerated and more robust suicidal NETosis in response to S. aureus.

Fig. 2.

(A) Neutrophils were cultured with S. aureus [multiplicity of infection (MOI) = 10] and primary degranulation [surface CD63 (sCD63)] by neutrophils (Ly6G+CD11b+) was quantified by flow cytometry. Median fluorescence intensity (MFI) normalized to an isotype (Iso) control. Each point represents neutrophils isolated from a single mouse (n = 14). (B) Mice were systemically infected (inf.) with S. aureus (CFU = 2 × 107). At 4 dpi, organs were homogenized and primary degranulation by neutrophils was quantified by flow cytometry. MFI normalized to an isotype control. Each point represents a single mouse (mock, n = 11) (WT; inf., n = 13) (A9−/−; inf., n = 16). (C and D) Neutrophils were cultured with S. aureus (MOI = 10). (C) Representative images of neutrophils (red) stimulated for 2 hours with a nuclease-deficient (Δnuc) strain of S. aureus (green) are provided. Extracellular DNA was stained using Helix NP Blue. (D) The percentage of neutrophils undergoing suicidal NETosis (dead: extracellular dsDNA+MPO+H3Cit+) in response to S. aureus was quantified by flow cytometry. Each point represents neutrophils isolated from a single mouse (n = 9). (E) Mice were systemically infected with S. aureus (CFU = 2 × 107). At 4 dpi, organs were homogenized and the percentage of neutrophils undergoing suicidal NETosis was quantified by flow cytometry. Each point represents a single mouse (mock, n = 6) (WT; inf., n = 9) (A9−/−; inf., n = 12). Two-way ANOVA with (A and D) Sidak’s or (B and E) Tukey multiple comparisons test (*P ≤ 0.05, **P ≤ 0.01, and ****P ≤ 0.0001).

Release of enzymes from primary granules into the cytosol is a precursor to NETosis (45, 46); therefore, reduced primary degranulation could imply elevated NETosis. To identity NETs, a nonmembrane permeable dye was used to fluorescently stain the DNA backbone of NETs. After a 2-hour culture with S. aureus, extracellular DNA structures consistent with NET formation were more prevalent in cultures containing A9−/− neutrophils compared to WT by confocal microscopy (Fig. 2C). To more accurately quantify vital and suicidal NETosis, we modified a flow cytometry–based assay that has been applied in vitro and in vivo as a high-throughput, quantitative method to identify neutrophils undergoing NETosis (4751). Neutrophils undergoing NETosis were identified by the presence of extracellular double-stranded DNA (dsDNA), MPO, and histone citrulline (H3Cit), while a fluorescent dye allowed for monitoring of the cell membrane integrity to differentiate vital from suicidal NETosis. Thus, neutrophils with permeabilized cell membranes that are positive for extracellular dsDNA, MPO, and H3Cit were defined as having undergone suicidal NETosis, and neutrophils positive for extracellular dsDNA, MPO, and H3Cit and with intact cell membranes were defined as having undergone vital NETosis (gating scheme provided in fig. S2A). WT and A9−/− neutrophils cultured with S. aureus demonstrated similar kinetics of vital NETosis, maximizing at 30 min (fig. S2B). However, the percentage of A9−/− neutrophils undergoing suicidal NETosis was heightened from 30 to 240 min relative to WT (Fig. 2D and fig. S2C). Consistent with increased suicidal NETosis, supernatants from cultures containing A9−/− neutrophils contained higher concentrations of NET DNA compared to supernatants isolated from cultures with WT neutrophils (fig. S2D). The accelerated suicidal NETosis by A9−/− neutrophils occurs before nuclease secretion by S. aureus. Specifically, stimulating the Sae sensory system of S. aureus to promote nuclease expression (52, 53) required 2 hours for nuclease activity in the supernatant to exceed the background activity observed in cultures containing a S. aureus strain lacking nuclease (Δnuc; fig. S2E). These data indicate an accelerated and more robust suicidal NETosis by A9−/− neutrophils in response to S. aureus.

To confirm that the flow cytometry–based strategy was monitoring NETosis and not other forms of cell death, an array of controls were used. First, the use of isotype control antibodies demonstrated that nonspecific antibody binding did not account for the positive staining of MPO and H3Cit (fig. S2F). Second, we used Padi4tm1.1Kmow/J (PAD4−/−) neutrophils that do not undergo NETosis in response to most stimuli (54). Consistent with an inability to NET, PAD4−/− neutrophils have substantially reduced extracellular MPO and H3Cit compared to WT neutrophils in response to S. aureus (fig. S2F). In addition, neutrophils cultured with a strain of S. aureus with reduced lytic activity (agr::tet) (55) had comparable NETosis to a WT strain (fig. S2G). Last, to identify whether NET antigens produced by neutrophils undergoing NETosis can contaminate neighboring non-NETing neutrophils, a coculture of WT and fluorescently labeled PAD4−/− neutrophils were stimulated with S. aureus. Only WT neutrophils robustly stained positive for NETosis (fig. S2H), indicating that accumulation of NET antigens on neutrophils not undergoing NETosis only marginally contributes to positive staining. These results demonstrate that the flow cytometry–based approach is specific to neutrophils undergoing NETosis and is not confounded by alternative forms of cell death.

Extracellular calprotectin acts as a chemoattractant (18, 19) and DAMP (20, 21), which may influence the neutrophil response to S. aureus. Therefore, neutrophils were cultured with S. aureus in the presence of recombinant calprotectin. The addition of exogenous calprotectin had no effect on degranulation or NETosis (fig. S3, A to C), indicating that the endogenous expression of S100A9 regulates neutrophil function in response to S. aureus.

To determine whether the heightened suicidal NETosis observed in vitro was present in A9−/− mice, mice were infected and the percentage of neutrophils undergoing NETosis was quantified by flow cytometry 4 dpi. Coinciding with reduced primary degranulation (Fig. 2B) and bacterial burdens (Fig. 1B), suicidal NETosis was increased in the heart of A9−/− mice but not significantly different in the liver and kidney relative to WT (Fig. 2E and fig. S3D). Vital NETosis was comparable between WT and A9−/− mice (fig. S3E). An enzyme-linked immunosorbent assay (ELISA)–based approach to identifying NET structures has been used successfully to quantify NET DNA in vivo (5658). Consistent with an increased percentage of neutrophils undergoing suicidal NETosis, an increased abundance of NETs was quantified from the supernatant of heart tissue from A9−/− mice compared to WT by ELISA (fig. S3F). Thus, A9−/− neutrophils in the heart have the strongest skewing toward suicidal NETosis during S. aureus infection coinciding with the largest decrease in bacterial burdens.

Mitochondrial O2 increases suicidal NETosis in the heart

NADPH oxidase–derived ROS mediates suicidal NETosis (59); however, modulation of NADPH oxidase activity likely does not account for S100A9 regulation of suicidal NETosis since the respiratory burst is comparable between A9−/− and WT neutrophils in vivo (fig. S1F). An NADPH oxidase–independent form of NETosis, relying solely on mitochondrial-derived ROS, has been described (60). Therefore, intracellular S100A9 could influence suicidal NETosis by altering the production of mitochondrial-derived ROS. To quantify mitochondrial O2 generation, neutrophils were stained with a fluorescent dye that localizes to mitochondrial structures and fluoresces upon oxidation by O2. Consistent with a role for mitochondrial O2, A9−/− neutrophils cultured with S. aureus maintained higher levels of mitochondrial O2 from 60 to 240 min compared to WT (Fig. 3, A and B, and fig. S4A). Further, mitochondrial O2 production by neutrophils was increased in the heart but comparable in the kidney and liver of A9−/− mice relative to WT, 4 dpi (Fig. 3C and fig. S4B). Therefore, A9−/− neutrophils in the heart produce more mitochondrial O2 in response to S. aureus, which correlates with increased suicidal NETosis.

Fig. 3. Increased mitochondrial O2 heightens suicidal NETosis in A9−/− neutrophils responding to S. aureus.

Fig. 3.

(A and B) Neutrophils were cultured with S. aureus (MOI = 10). (A) Neutrophils were stimulated with S. aureus for 1 hour, and representative images of mitochondrial (Mito.) O2 (red; MitoSOX) and biomass (green; MitoTracker) are provided. Nuclear DNA was stained (blue; Hoechst). (B) Neutrophils (Ly6G+CD11b+) were cultured with S. aureus, and production of mitochondrial O2 was quantified by flow cytometry. MitoSOX MFI was normalized by MitoTracker MFI. Each point represents neutrophils isolated from a single mouse (n = 9). (C) Mice were systemically infected (inf.) with S. aureus (CFU = 2 × 107). At 4 dpi, organs were homogenized and production of mitochondrial O2 in neutrophils was quantified in the heart by flow cytometry. MitoSOX MFI was normalized by MitoTracker MFI. Each point represents a single mouse (mock, n = 6) (WT; inf., n = 9) (A9−/−; inf., n = 12). (D to G) Neutrophils pretreated with (D and E) rotenone (Rot.; 0.5 μM) for 15 min or (F and G) MitoTEMPO (mT; 0.5 μM) for 2 hours were cultured with S. aureus (MOI = 10). Neutrophils were stimulated with S. aureus, and (D and F) the production of mitochondrial O2 and (E and G) the percentage of neutrophils undergoing suicidal NETosis (Dead: extracellular dsDNA+MPO+H3Cit+) were quantified by flow cytometry. (D and F) MitoSOX MFI was normalized by MitoTracker MFI. Each point represents neutrophils isolate from a single mouse (n = 5). Two-way ANOVA with (B) Sidak’s or (C to G) Tukey multiple comparisons test (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001).

To determine whether increased mitochondrial O2 alters the response of A9−/− neutrophils to S. aureus, neutrophils were treated with rotenone to increase or MitoTEMPO to quench mitochondrial O2 production. In addition to increasing mitochondrial O2 levels (Fig. 3D and fig. S4C), rotenone accelerated and enhanced suicidal NETosis (Fig. 3E and fig. S4D) and decreased primary degranulation (fig. S4E) in response to S. aureus, to levels similar to A9−/−. Conversely, quenching mitochondrial O2 using MitoTEMPO (Fig. 3F and fig. S4C) reduced the percentage of A9−/− neutrophils undergoing suicidal NETosis in response to S. aureus (Fig. 3G and fig. S4D), while primary degranulation was modestly increased (fig. S4E). Suicidal NETosis was fully impaired in MitoTEMPO-treated WT neutrophils cultured with S. aureus (Fig. 3G). Mitochondrial O2 did not influence all forms of NETosis as vital NETosis was unaffected by rotenone and MitoTEMPO treatments (fig. S4F). Thus, mitochondrial O2 regulates suicidal NETosis in response to S. aureus.

Since MitoTEMPO treatment reduces suicidal NETosis in vitro, treating A9−/− mice with MitoTEMPO to reduce the production of mitochondrial O2 was hypothesized to enhance disease pathology in the heart during S. aureus infection. Therefore, mice were intraperitoneally injected with MitoTEMPO daily starting 24 hours before infection. Treatment with MitoTEMPO during infection was sufficient to decrease mitochondrial O2 levels in neutrophils within the heart, liver, and kidney of A9−/− mice to levels comparable to WT (Fig. 4A and fig. S5A). The activity of MitoTEMPO was specific to mitochondrial O2 as overall ROS levels in neutrophils were unchanged (fig. S5B). Furthermore, while vital NETosis was unaffected by MitoTEMPO (fig. S5C), the percentage of neutrophils undergoing suicidal NETosis was reduced (Fig. 4B and fig. S5D), and primary degranulation was increased (fig. S5E) to similar levels as WT in the heart of A9−/− mice. Corresponding with reduced suicidal NETosis, MitoTEMPO treatment increased bacterial burdens in the heart (Fig. 4C) and mortality (Fig. 4D) of A9−/− mice to levels comparable to WT. Treatment with MitoTEMPO did not alter mouse weight (fig. S5F), NETosis (fig. S5, C and D), or bacterial burdens (fig. S5G) in the liver and kidney. These results demonstrate that increased mitochondrial O2 benefits neutrophil function in the heart by enhancing suicidal NETosis in response to S. aureus, thereby reducing bacterial burdens.

Fig. 4. MitoTEMPO treatment of A9−/− mice reduces suicidal NETosis coinciding with enhanced lethality and heart colonization.

Fig. 4.

Mice were treated with MitoTEMPO (mT; 0.7 mg/kg) by intraperitoneal injection 24 hours before and every 24 hours during systemic infection (inf.) with S. aureus (A to C, CFU = 2 × 107; D, CFU = 5 × 107). (A to C) At 4 dpi, organs were homogenized, and (A) the production of mitochondrial O2 by neutrophils (Ly6G+CD11b+) and (B) the percentage of neutrophils undergoing suicidal NETosis (Dead: extracellular dsDNA+MPO+H3Cit+) were quantified by flow cytometry, and (C) CFU was counted using spot plating (LoD). (A) MitoSOX MFI was normalized by MitoTracker MFI. Each point represents a single mouse (mock; mock/mT; WT, n = 4) (mock; mock/mT; A9−/−, n = 3) (inf.; mock; WT, n = 5) (inf.; mock; A9−/−, n = 6) (inf.; mT; WT, n = 9) (inf.; mT; A9−/−, n = 10). (D) During the infection, mouse survival was monitored. Each point represents the percentage of living mice (mock; mock; WT/A9−/−, n = 7) (mock; mT; WT/A9−/−, n = 8) (inf.; mock; WT, n = 13) (inf.; mock; A9−/−, n = 15) (inf.; mT; WT, n = 19) (inf.; mT; A9−/−, n = 21). (A to C) Two-way ANOVA with Tukey multiple comparisons test or (D) log-rank (Mantel-Cox) test (*P ≤ 0.05, **P ≤ 0.01, and ****P ≤ 0.0001).

Modulating NET formation alters S. aureus disease outcome

While increased suicidal NETosis correlates to reduced heart colonization during systemic infection (Figs. 2 and 4), the antibacterial activity of NETs can vary in response to S. aureus (1012). In addition, the role of NET formation in the heart during S. aureus infection has not been explored. If suicidal NETosis is protective during systemic S. aureus infections, then PAD4−/− mice, where the neutrophils cannot undergo NETosis in response to most stimulations (fig. S2F) (54), should exhibit increased susceptibility. Following infection, PAD4−/− mice had increased mortality relative to WT (Fig. 5A) despite decreased weight loss (fig. S6A). Furthermore, of mice surviving to 4 dpi, bacterial burdens were increased in the heart of PAD4−/− mice compared to WT mice (Fig. 5B). The secretion of a nuclease allows S. aureus to escape NET-mediated antibacterial activity by degrading the DNA backbone of NETs (10). Consistent with NET formation protecting the host, mice systemically infected with Δnuc showed reduced mortality (Fig. 5A) and weight loss (fig. S6A) relative to WT infected mice. Further, lower bacterial burdens were observed in the heart and liver of mice infected with a Δnuc strain relative to WT 4 dpi (Fig. 5B). These results demonstrate that NET formation contributes to protecting the host from systemic S. aureus infections and reducing bacterial burdens in the heart.

Fig. 5. NET formation contributes to the protection of mice during systemic infection with S. aureus.

Fig. 5.

Mice were systemically infected with S. aureus (CFU = 2 × 107). (A) During the infection, mouse survival was monitored. Each point represents the percentage of living mice (WT; WT, n = 16) (WT; Δnuc, n = 20) (PAD4−/−; WT, n = 13). (B) At 4 dpi, organs were homogenized and CFU was counted using spot plating (LoD). Each point represents a single mouse (WT; WT, n = 5) (WT; Δnuc, n = 11) (PAD4−/−; WT, n = 3). (A) Log-rank (Mantel-Cox) test or (B) two-way ANOVA with Tukey multiple comparisons test (*P ≤ 0.05, **P ≤ 0.01, and ****P ≤ 0.0001).

NET formation by A9−/− neutrophils enhances S. aureus killing in the presence of Mφs

NET formation aids in protecting the host from systemic S. aureus infections (Fig. 5). The accelerated and robust suicidal NETosis by A9−/− neutrophils in response to S. aureus (Fig. 2) provides a powerful tool to assess NET-related biology. Therefore, we hypothesized that enhanced suicidal NETosis by A9−/− neutrophils would render them more bactericidal. However, in vitro, A9−/− neutrophils did not restrict S. aureus growth better than WT (Fig. 6A). Thus, suicidal NETosis alone does not account for the increased protection of A9−/− mice from systemic S. aureus infections.

Fig. 6. NET formation from A9−/− neutrophils better restrict S. aureus growth in the presence of Mφs.

Fig. 6.

Immune cells were cultured with S. aureus (MOI = 1). (A) Neutrophil (Neut.) restriction of S. aureus growth was quantified by CFU spot plating. Percent growth of S. aureus (SA) calculated relative to S. aureus growth in the absence of neutrophils. Each point represents the mean result (biological triplicate) of neutrophils isolated from a single mouse (n = 4). (B to D) Neutrophil-Mφ coculture (ratio = 1:1) restriction of S. aureus growth was quantified by CFU spot plating. Percent growth of S. aureus calculated relative to S. aureus growth in the absence of immune cells. (B) Representative spot plating from a single experiment is provided. (C) Immune cells cultured with S. aureus in the presence of deoxyribonuclease (DNase) (8 U/ml). Each point represents the mean result (biological triplicate) of immune cells isolated from a single mouse (n = 3). (E) Mφ restriction of S. aureus growth was quantified by CFU spot plating. NETs or apoptotic debris (apop.) used for S. aureus opsonization were isolated from neutrophils stimulated with phorbol 12-myristate 13-acetate (PMA) (100 nM) for 4 hours or an anti-FAS antibody (100 ng/ml) for 16 hours. Percent growth of S. aureus calculated relative to S. aureus growth in the absence of immune cells. Mφs cultured with S. aureus in the presence of DNase (8 U/ml). Each point represents the mean result (biological triplicate) of Mφs isolated from a single mouse (n = 4). Two-way ANOVA with (A) Sidak’s or (B to E) Tukey multiple comparisons test (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001).

Neutrophils and Mφs can cooperatively combat intracellular bacterial pathogens during infection (3336), but whether similar cooperative mechanisms exist in combating extracellular pathogens, such as S. aureus, is unclear. During S. aureus infection, the ratio of neutrophils to Mφs is comparable in the liver and kidney of WT and A9−/− mice as neutrophils outnumbered Mφs by 2-fold in the liver and 6.5-fold in the kidney (fig. S6B). In the heart, the neutrophil/Mφ ratio was 4.6 in WT mice compared to 1.3 in A9−/− mice, a difference that can be attributed to a reduction of live neutrophils observed in the heart of A9−/− mice (fig. S6B) (22) and possibly due to increased suicidal NETosis (Fig. 2E). Cocultures containing neutrophils isolated from the bone marrow and bone marrow–derived Mφs at a ratio of 1:1 were stimulated with S. aureus. Consistent with increased antibacterial activity, cocultures containing neutrophils and Mφs restricted S. aureus growth better (Fig. 6B) than cultures containing equal numbers of neutrophils (Fig. 6A) or Mφs (fig. S6C) alone. Further, cocultures containing A9−/− neutrophils with either WT or A9−/− Mφs restricted S. aureus growth better (≥1.3-log) than cocultures containing WT neutrophils at 6 and 12 hours (Fig. 6B). Skewing the coculture so that either Mφs outnumbered neutrophils or neutrophils outnumber Mφs at a ratio of 5:1 or higher rapidly ablated the enhanced bactericidal activity of cocultures containing A9−/− neutrophils (fig. S6D). These results demonstrate that A9−/− neutrophils have increased antibacterial activity in the presence of Mφs.

To determine whether enhanced suicidal NETosis accounts for increased bacterial killing in the presence of Mφs, neutrophil-Mφ cocultures were treated with deoxyribonuclease (DNase) to degrade the DNA backbone of NETs, as previously described (11, 56). DNase treatment ablated the improved restriction of S. aureus growth in cocultures containing A9−/− neutrophils to levels lower than cocultures containing WT neutrophils (Fig. 6C). A similar, but less pronounced, phenotype was observed in cultures containing only neutrophils (fig. S6E), but no effect was observed on Mφ killing of S. aureus (fig. S6F). In addition, neutrophil-Mφ cocultures containing PAD4−/− neutrophils failed to restrict S. aureus growth and cocultures containing WT neutrophils (Fig. 6D). Thus, NET formation provides an advantage for neutrophils engaging S. aureus, and this is enhanced by the presence of Mφs.

Nuclease secretion protects S. aureus from NET-mediated killing (10). Since NET formation in the presence of Mφs contributes to bacterial killing, we hypothesized that growth of Δnuc should be restricted in neutrophil-Mφ cocultures. In neutrophil-Mφ cocultures, Δnuc growth was reduced relative to WT S. aureus (Fig. 6D). Expression of nuclease in trans (Δnuc pnuc) complemented this phenotype to levels comparable to cocultures containing WT S. aureus. A similar, but less pronounced, phenotype was observed in cultures containing only neutrophils (fig. S6G), but the growth of WT and Δnuc strains were comparably restricted in cultures containing Mφs alone (fig. S6H). Combined with the observation that detectable nuclease activity in the supernatant occurs after 2 hours (fig. S2E), these results suggest that the accelerated and more robust suicidal NETosis by A9−/− neutrophils may outpace and/or overwhelm nuclease activity, giving A9−/− neutrophils an advantage when combating S. aureus in the presence of Mφs.

NET formation in the presence of Mφs limits S. aureus growth (Fig. 6, B to D), but neutrophils may perform other functions contributing to S. aureus killing. To determine whether NET formation is sufficient to increase Mφ-mediated killing of S. aureus, NET structures were isolated from the supernatant of phorbol 12-myristate 13-acetate (PMA)–stimulated neutrophils as previously described (61). Equal concentrations of NETs from WT or A9−/− neutrophils were added to S. aureus in culture media and then transferred to Mφs. NETs isolated from WT and A9−/− neutrophils comparably enhanced Mφ restriction of S. aureus growth (Fig. 6E), demonstrating that NETs from A9−/− neutrophils are not more antibacterial than WT. Further, DNase treatment reduced the restriction of S. aureus growth by Mφs to levels comparable to using serum as an opsonin. Stimulation with an anti-Fas antibody to trigger apoptosis caused neutrophils to release less DNA into the supernatant (fig. S6I) and failed to enhance Mφ killing of S. aureus (Fig. 6E), suggesting that not all forms of neutrophil cell death enhance the antibacterial activity of Mφs. These data demonstrate that NETs increase the antibacterial activity of Mφs toward S. aureus.

NETs enhance phagocytosis of S. aureus by Mφs

S. aureus has multiple strategies to avoid phagocytosis (6264); however, entrapment of S. aureus in NETs may aid phagocytosis by Mφs. To quantify phagocytosis, immune cells were cultured with fluorescently labeled S. aureus. Phagocytosis of S. aureus by Mφs was enhanced in cocultures containing A9−/− neutrophils relative to cocultures with WT neutrophils (Fig. 7A and fig. S7A). Phagocytosis by neutrophils in cocultures was comparable (fig. S7B). Pretreating Mφs with cytochalasin D prevented phagocytosis of S. aureus by Mφs in the cocultures but not neutrophils (fig. S7C) and prevented cocultures containing A9−/− neutrophils from having enhanced antibacterial activity (Fig. 7B). These data suggest that phagocytosis by Mφs is required for A9−/− neutrophils to enhance antibacterial activity in response to S. aureus.

Fig. 7. NET formation enhances phagocytosis of S. aureus by Mφs.

Fig. 7.

(A to E) Immune cells were cultured with fluorescently labeled S. aureus (MOI = 10). (A) Phagocytosis of S. aureus by Mφs in coculture (ratio = 1:1) with neutrophils (Neut.) was quantified by flow cytometry. Background MFI was subtracted from each time point. Each point represents immune cells isolated from a single mouse (n = 3). (B) Mφs were pretreated with cytochalasin D (Cyto. D; 10 μg/ml) for 1 hour before adding neutrophils and S. aureus. Percent growth of S. aureus was calculated relative to S. aureus growth in the absence of immune cells. Each point represents the mean result (biological triplicate) of immune cells isolated from a single mouse (n = 4). (C and D) Phagocytosis of S. aureus by Mφs in coculture with neutrophils was quantified by flow cytometry. Background MFI was subtracted from each time point. (C) Immune cells cultured with S. aureus in the presence of DNase (8 U/ml). Each point represents immune cells isolated from a single mouse (C, n = 5; D, n = 3). (E) Phagocytosis of S. aureus by Mφs was quantified by flow cytometry. Background MFI was subtracted from each time point. NETs used for S. aureus opsonization were isolated from neutrophils stimulated with PMA (100 nM) for 4 hours and cultured with Mφs in the presence of DNase (8 U/ml). Each point represents immune cells isolated from a single mouse (n = 4). (F) Mice were systemically infected with a fluorescent strain of S. aureus (pSarA_sfGFP; CFU = 2 × 107). At 4 dpi, organs were homogenized and S. aureus levels within Mφs (CD11b+F4/80+Ly6G) in the heart were quantified by flow cytometry. Background MFI from uninfected mice was subtracted from infected. Each point represents a single mouse (mock, n = 3) (WT; inf., n = 9) (A9−/−; inf., n = 12). Two-way ANOVA with (A) Sidak’s or (B to F) Tukey multiple comparisons test (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001).

To identify whether the enhanced phagocytosis by Mφs cocultured with A9−/− neutrophils was NET dependent, cocultures were treated with DNase to degrade the DNA backbone of NETs. Treating cocultures containing A9−/− neutrophils with DNase reduced phagocytosis of S. aureus by Mφs to levels similar to cocultures containing WT neutrophils (Fig. 7C). Consistent with NETs facilitating phagocytosis by Mφs, neutrophil-Mφ cocultures containing PAD4−/− neutrophils did not increase phagocytosis of S. aureus by Mφs, while cocultures stimulated with Δnuc enhanced phagocytosis of S. aureus by Mφs (Fig. 7D and fig. S7A). Last, adding isolated NETs from PMA-stimulated neutrophils to S. aureus increased phagocytosis by Mφs to greater levels than opsonizing S. aureus in serum, which was prevented by treating with DNase (Fig. 7E). Thus, NETs may act as a pseudo-opsonin that facilitates phagocytosis by Mφs.

To determine whether enhanced suicidal NETosis increases phagocytosis of S. aureus by Mφs in vivo, mice were infected with a fluorescent S. aureus strain (pSarA_sfGFP) (65). Consistent with increased suicidal NETosis (Fig. 2E), Mφs in the heart of A9−/− mice had higher levels of internalized S. aureus relative to WT (Fig. 7F and fig. S7D), which was not observed in the kidney and liver (fig. S7D). Internalized S. aureus levels in neutrophils was decreased in the heart and kidney and comparable in the liver of A9−/− mice (fig. S7E). These results demonstrate that increased suicidal NETosis correlates to enhanced internalization of S. aureus by Mφs, which may contribute to the specific reduction in bacterial burdens in the heart of A9−/− mice.

NETs transfer AMPs to Mφs during S. aureus infection

Despite the antimicrobial activity of phagolysosomes, S. aureus can persist and replicate within Mφs (23, 31, 32). While engulfment of apoptotic neutrophils transfers AMPs to Mφs in response to intracellular bacterial pathogens (3336), NET formation may provide an alternative means to transfer neutrophil-specific AMPs to Mφs in response to extracellular pathogens, such as S. aureus. Mφs expressed low levels of lactoferrin relative to neutrophils before stimulation (fig. S8A). However, Mφs in cocultures containing A9−/− neutrophils accumulated higher levels of lactoferrin in response to S. aureus compared to cocultures with WT neutrophils after 120 min (Fig. 8A and fig. S8B). This phenotype was not unique to lactoferrin as the abundance of other neutrophil-specific AMPs, including proteinase 3 (PR3) and neutrophil elastase, was increased in Mφs from cocultures containing A9−/− neutrophils relative to WT in response to S. aureus (Fig. 8B and fig. S8C). S. aureus did not cause AMPs to accumulate in Mφs in the absence of neutrophils (fig. S8D). DNase treatment of cocultures containing A9−/− neutrophils reduced the abundance of AMPs in Mφs to levels comparable to cocultures with WT neutrophils (Fig. 8C and fig. S8E). Thus, NET formation transfers neutrophil-specific AMPs to Mφs coinciding with enhanced antibacterial activity of Mφs.

Fig. 8. NET formation transfers neutrophil-specific AMPs to Mφs.

Fig. 8.

(A to F) Immune cells were cultured with S. aureus (MOI = 10). (A to D) The intracellular (Intra.) abundance of lactoferrin, PR3, and elastase within Mφs in coculture (ratio = 1) with neutrophils (Neut.) following stimulation with S. aureus were quantified by flow cytometry. MFI was normalized to an isotype control. (C) Immune cells were cultured with S. aureus in the presence of DNase (8 U/ml). Each point represents immune cells isolated from a single mouse (A, n = 6; B and D, n = 3; C, n = 5). (E) Intracellular abundance of lactoferrin within Mφs following stimulation with S. aureus was quantified by flow cytometry. MFI was normalized to an isotype control. NETs used for S. aureus opsonization were isolated from neutrophils stimulated with PMA (100 nM) for 4 hours and cultured with Mφs in the presence of DNase (8 U/ml). Each point represents immune cells isolated from a single mouse (n = 4). (F) Cocultures were stimulated with S. aureus, and after 2 hours, neutrophils and Mφs were isolated by fluorescent sorting. Lysates from isolated cells were quantified for neutrophil elastase activity and normalized by cell number (nd, no activity detected). Each point represents the mean result (biological duplicate) of immune cells isolated from a single mouse (n = 3). (G) Mice were systemically infected with S. aureus (CFU = 2 × 107). At 4 dpi, organs were homogenized and intracellular lactoferrin, PR3, and elastase levels within Mφs (CD11b+F4/80+Ly6G) in the heart were quantified by flow cytometry. MFI was normalized by an isotype control. Each point represents a single mouse (mock, n = 3) (WT; inf., n = 9) (A9−/−; inf., n = 12). Two-way ANOVA with (A) Sidak’s or (B to E and G) Tukey multiple comparisons test (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001).

Since NET formation transfers AMPs to Mφs, we predicted that the Δnuc strain of S. aureus would allow increased transfer compared to WT. Mφs in cocultures accumulated higher levels of AMPs in response to Δnuc relative to cocultures stimulated with a WT strain (Fig. 8D and fig. S8, B, C, and F). Expression of nuclease in trans complemented the abundance of AMPs in Mφs to levels comparable to cocultures stimulated with a WT strain. In addition, Mφs in cocultures containing PAD4−/− neutrophils have a decreased abundance of AMPs in response to Δnuc, which are similar to levels observed using Δnuc pnuc. Last, isolated NETs from PMA-stimulated neutrophils added to S. aureus were sufficient to increase the abundance of lactoferrin in Mφs, while DNase treatment prevented this accumulation (Fig. 8E). Therefore, NET formation acts as a conduit to transfer neutrophil-specific AMPs to Mφs, and secretion of nuclease by S. aureus combats AMP transfer.

It has been previously demonstrated that NETs transfer neutrophil elastase to Mφs and that elastase retains its activity within the Mφ (56). The elevated suicidal NETosis by A9−/− neutrophils efficiently transfers AMPs to Mφs in response to S. aureus (Fig. 8, A to E, and fig. S8, B, C, E, and F). To determine whether neutrophil elastase transferred by A9−/− neutrophils to Mφs retained enzymatic activity, cocultures were stimulated with S. aureus, and neutrophils and Mφs were fluorescently sorted after 120 min. Lysates from isolated immune cells were quantified for neutrophil elastase activity. Neutrophil elastase activity was not detected in Mφs from cocultures with WT neutrophils; however, in cocultures containing A9−/− neutrophils, neutrophil elastase activity in Mφs was detectable (Fig. 8F), coinciding with the transfer of neutrophil elastase to Mφs (Fig. 8B). These results suggest that the enhanced suicidal NETosis by A9−/− neutrophil transfers biologically active AMPs to Mφs in response to S. aureus.

To determine whether increased NET formation facilitates the accumulation of neutrophil-specific AMPs in Mφs in vivo, mice were infected, and lactoferrin, PR3, and elastase abundance in Mφs was quantified by flow cytometry. Correlating with increased suicidal NETosis (Fig. 2E), Mφs in the heart of A9−/− mice accumulated higher levels of neutrophil-specific AMPs compared to WT mice (Fig. 8G and fig. S8G), which was not observed in the liver and kidney (fig. S8G). Neutrophil AMP levels were comparable across organs (fig. S8H). These results demonstrate that increased suicidal NETosis enhances transfer of neutrophil-specific AMPs to Mφs, which correlates with the specific reduction in bacterial burdens in the heart of A9−/− mice.

NET formation in the presence of Mφs enhances killing of multiple bacterial pathogens

Since neutrophils enhance S. aureus killing by Mφs through the formation of NETs, we reasoned that this process may occur in response to other NET-inducing bacterial pathogens from different phylogenetic lineages, including S. pneumoniae (66) and P. aeruginosa (67). As observed for S. aureus, A9−/− neutrophils have accelerated and more robust suicidal NETosis in response to S. pneumoniae and P. aeruginosa relative to WT (Fig. 9A and fig. S9A). In addition, neutrophil-Mφ cocultures containing A9−/− neutrophils restricted S. pneumoniae and P. aeruginosa growth better than cocultures containing WT neutrophils (Fig. 9B). DNase treatment prevented the improved restriction of bacterial growth in cocultures containing A9−/− neutrophils, indicating a dependence on NET formation. A similar but smaller restriction in S. aureus growth was observed in neutrophil cultures (fig. S9B); however, A9−/− neutrophils did not restrict P. aeruginosa growth better than WT despite NETs facilitating killing, and NETs alone were not antibacterial toward S. pneumoniae (fig. S9B). DNase treatment did not alter Mφ killing in the absence of neutrophils (fig. S9C). These results suggest that NET formation broadly increases killing of extracellular bacterial pathogens in the presence of Mφs.

Fig. 9. NET formation better restricts growth of multiple bacterial pathogens in the presence of Mφs.

Fig. 9.

Immune cells were cultured with S. aureus, S. pneumoniae, and P. aeruginosa (A, C, and D, MOI = 10; B, MOI = 1). (A) Neutrophils (Neut.) were stimulated with bacteria and the percentage of neutrophils (Ly6G+CD11b+) undergoing suicidal NETosis (Dead: extracellular dsDNA+MPO+H3Cit+) was quantified by flow cytometry. Each point represents neutrophils isolated from a single mouse (n = 3). (B) Neutrophil-Mφ coculture (ratio = 1:1) restriction of bacterial growth was quantified by CFU spot plating. Percent growth of bacteria was calculated relative to bacterial growth in the absence of immune cells. Immune cells cultured with bacteria in the presence of DNase (8 U/ml). Each point represents the mean result (biological triplicate) of immune cells isolated from a single mouse (n = 3). (C and D) Cocultures were stimulated with fluorescently labeled bacteria and (C) phagocytosis of bacteria by Mφs, and (D) the level of intracellular lactoferrin within Mφs was quantified by flow cytometry. Immune cells cultured with bacteria in the presence of DNase (8 U/ml). (C) Background MFI was subtracted from each time point, and (D) MFI was normalized by an isotype control. Each point represents immune cells isolated from a single mouse (n = 3). Two-way ANOVA with (A) Sidak’s or (B to D) Tukey multiple comparisons test (*P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001).

NET formation facilitates phagocytosis of S. aureus by Mφs (Fig. 7) and transfers neutrophil-specific AMPs to Mφs (Fig. 8). Similarly, phagocytosis of S. pneumoniae and P. aeruginosa by Mφs was enhanced in cocultures containing A9−/− neutrophils relative to cocultures with WT neutrophils (Fig. 9C and fig. S9D). Further, Mφs in cocultures containing A9−/− neutrophils accumulated higher levels of lactoferrin compared to cocultures with WT neutrophils in response to S. pneumoniae and P. aeruginosa (Fig. 9D and fig. S9E). DNase treatment reversed both of these phenotypes (Fig. 9, C and D). Thus, NET formation in the presence of Mφs appears to be an immune defense mechanism that broadly enhances antibacterial activity against multiple distinct bacterial pathogens from different phylogenetic lineages.

DISCUSSION

We report that A9−/− neutrophils produce higher levels of mitochondrial O2 (Figs. 3 and 4) in response to S. aureus. As a result of increased levels of mitochondrial O2, A9−/− neutrophils undergo accelerated and robust suicidal NETosis in response to multiple bacterial pathogens (Figs. 2D and 9A), which coincides with increased survival of A9−/− mice during systemic S. aureus infection (Fig. 1A). This identifies intracellular S100A9 as a critical molecular rheostat in neutrophil function. Enhanced suicidal NETosis by A9−/− neutrophils does not increase bacterial killing in isolation (Fig. 6A and fig. S9B) but augments killing in the presence of Mφs (Figs. 6B and 9B). NET formation acts as a conduit to increase phagocytosis of multiple phylogenetically distinct bacterial pathogens by Mφs (Figs. 7 and 9C) and transfers neutrophil-specific AMPs to Mφs (Figs. 8 and 9D). By using A9−/− neutrophils as a tool to assess NET-related biology, these results demonstrate that NET formation enables neutrophils to broadly combat extracellular bacterial pathogens cooperatively with Mφs. A graphical model demonstrating how NET formation augments the antibacterial activity of Mφs is provided in Fig. 10.

Fig. 10. Proposed model for how accelerated NET formation by A9−/− neutrophils enhances Mφ antibacterial activity.

Fig. 10.

Upon engaging S. aureus, WT neutrophils undergo suicidal NETosis after 4 hours. However, S. aureus secretes a nuclease that degrades NETs and uncouples the cooperation between neutrophils and Mφs during infection. In contrast, A9−/− neutrophils in response to S. aureus undergo comparable levels of suicidal NETosis as WT after 30 min. This accelerated and more robust NET formation outpaces/overwhelms S. aureus, which allows for increased phagocytosis of S. aureus into Mφs, transferring of neutrophil-specific AMPs to Mφs, and increased antibacterial activity. Therefore, NET formation acts as a conduit for neutrophils and Mφs to combat bacterial pathogens cooperatively during infection that is particularly important within the immunological niche of the heart. Created with BioRender.com.

Our study focused on how a deficiency in S100A9 enhances the antibacterial response, which allowed for the identification of a previously unidentified antibacterial mechanism. While the synergy in bactericidal activity between neutrophils and Mφs was exaggerated when using A9−/− neutrophils, it is important to note that NET formation by WT neutrophils also enhances the antibacterial activity of Mφs (Fig. 6B). However, expression of nuclease by S. aureus limits the capacity for WT neutrophils to cooperate with Mφs (Fig. 6D). These findings highlight S. aureus as a professional pathogen that is capable of uncoupling cooperation among innate immune cells through NET degradation. In addition, alterations in S100A9 abundance have been associated with many clinically relevant inflammatory states, such as autoimmunity (68, 69), cancer (7072), coronavirus disease 2019 (COVID-19) (73), and aging (74). As a result, changes in the abundance of S100A9 may render patient populations more or less susceptible to bacterial infections.

Calprotectin plays an integral role in nutritional immunity as bacterial burdens were reduced in the kidney and liver of A9−/− mice infected with Newman (16, 17); however, this was not observed in A9−/− mice infected with USA300 (LAC) (Fig. 1B). This difference in infection may be attributed to alterations in virulence (44). For example, Sae activation leads to transcription of a wide range of virulence factors, and Newman constitutively expresses the sae operon due to an amino acid substitution in the sensor histidine kinase SaeS (75). Since Sae activation plays a vital role in responding to phagocyte-related stressors (76) upstream of nuclease expression (52), this could provide one possible explanation as to why Newman and USA300 show some differences in pathology during infection.

Extracellular functions for calprotectin have been well described (1621), but intracellular S100A9 also contributes to disease pathology. Previous studies demonstrate that intracellular S100A9 regulates the respiratory burst (77), and we observe that A9−/− neutrophils have a heightened respiratory burst than WT neutrophils in response to S. aureus in vitro (fig. S1D). However, A9−/− and WT neutrophils produce comparable levels of ROS in vivo (fig. S1E), suggesting that the alterations to the respiratory burst are likely not accounting for the increased protection of A9−/− mice from systemic S. aureus infections. Instead, we provide evidence that intracellular S100A9 regulates mitochondrial homeostasis, whereby A9−/− neutrophils produce higher levels of mitochondrial O2 in response to S. aureus (Figs. 3 and 4). As a result, A9−/− neutrophils have enhanced suicidal NETosis and decreased primary degranulation (Figs. 2 and 4). Why the heart offers a unique niche for A9−/− neutrophil function is unclear. S100A9 can modulate glycolysis through the nitrosylation of glyceraldehyde phosphate dehydrogenase (78); therefore, it is possible that S100A9 directly or indirectly influences mitochondrial homeostasis and the generation of O2 from the electron transport chain, thereby linking S100A9 to mitochondrial metabolism. In addition, activation of the inositol-requiring enzyme 1α in response to S. aureus promotes heightened mitochondrial ROS production and NETosis (58). While inflammatory conditions of heightened endoplasmic reticulum (ER) stress correlate with increased levels of S100A9 (79, 80), whether intracellular S100A9 regulates ER homeostasis is unexplored. While the exact mechanism by which intracellular S100A9 alters mitochondrial homeostasis is unknown, the unique metabolic/immunologic niche of the heart may amplify suicidal NETosis in A9−/− neutrophils during infection. Data presented here demonstrate that A9−/− neutrophils in the heart produce more mitochondrial O2 during S. aureus infection, thereby enhancing suicidal NETosis, which is beneficial for the host during systemic S. aureus infections.

NETs are used to broadly combat bacterial infections. S. aureus (8, 9), Shigella flexneri (9), S. pneumoniae (66), Neisseria gonorrhoeae (81), and P. aeruginosa (67) trigger NETosis; however, the mechanism for the antimicrobial activity of NETs is enigmatic. In Mφs, impaired maturation of the lysosome causes internalized cargo to recycle to and accumulate on the extracellular membrane (82). We propose a model where altered phagosomal function in neutrophils results in suicidal NETosis, thereby preventing intracellular bacterial replication and enhancing the antimicrobial activity of Mφs. S. aureus can survive the antimicrobial stresses of the phagosome in neutrophils (83), which provides S. aureus a long-term reservoir to replicate unperturbed (84). Suicidal NETosis may offer a mechanism to expel intracellular bacteria from the cell while entrapping the bacteria in AMP-rich NETs. These NETs act as a pseudo-opsonin that heightens phagocytosis of bacteria into Mφs (Figs. 7 and 9) and transfers neutrophil-specific AMPs to Mφs (Fig. 8 and 9). Internalization of AMPs into a phagosome is particularly important because the extracellular release of elastase and many proteases bound to NETs limits their antimicrobial activity (8589). Thus, NETs may provide an efficient mechanism to transfer AMPs back to a phagosomal compartment within Mφs and restore the full activity of AMPs, which coincides with NET formation enhancing the killing of bacterial pathogens in the presence of Mφs (Figs. 5 and 9). Similar to nuclease secretion preventing NETs from eliciting direct antibacterial activity on S. aureus (10), nuclease secretion also can uncouple the NET-mediated cooperation between neutrophils and Mφs (Fig. 6D). We provide evidence that accelerated and more robust NET formation, observed in A9−/− neutrophils, can outpace/overwhelm nuclease activity and increase antibacterial activity in the presence of Mφs.

The transfer of neutrophil-specific AMPs to Mφs is not without precedent. NET formation allows for the transfer of neutrophil elastase to Mφs, which facilitates NET DNA translocation into the cytosol of Mφs and inducing the production of type I interferon by activating cyclic guanosine monophosphate–adenosine monophosphate synthase (cGAS) (56). We provide evidence that NETs transfer enzymatically active neutrophil elastase to Mφs in response to S. aureus (Fig. 8F). Similarly, in response to intracellular pathogens such as Legionella pneumophila (33) and Mycobacterium tuberculosis (3436), phagocytosis of infected apoptotic neutrophils transfers AMPs to Mφs, which enhances Mφ killing. However, apoptotic debris was unable to facilitate the same antibacterial enhancement of Mφs in response to S. aureus (Fig. 6E), suggesting that these mechanisms may be pathogen specific. The mechanism by which AMPs are delivered to the Mφs may also be critical to establishing the appropriate immune response. Mφs undergo anti-inflammatory responses following phagocytosis of apoptotic cells (90, 91), whereas necrotic cells (92, 93) and NETs (94) induce proinflammatory responses. The molecular events governing whether neutrophils undergo suicidal NETosis or apoptosis may be pathogen specific and play a critical function in regulating inflammation. Our results demonstrate that NET formation acts as a conduit to broadly enhance antimicrobial activity in the presence of Mφs in response to bacterial pathogens.

MATERIALS AND METHODS

Mice

C57BL/6J and B6.Cg-Padi4tm1.1Kmow/J mice were purchased from the Jackson Laboratory (JAX mice stock no. 000664 and no. 030315). B6.S100a9−/− mice were maintained in an accredited animal facility. Mice were housed two to five to a cage in specific pathogen–free conditions and randomly assigned to experimental groups. Food and water were provided ad libitum. All animal experiments were approved and performed in compliance with the Vanderbilt Institutional Animal Care and Use Committee.

Reagents

Antibodies specific for Ly6G, F4/80, CD35, and rabbit immunoglobulin G (IgG) were from BioLegend; CD11b was from Tonbo; CD63 was from BD Biosciences; and MPO, H3Cit, lactoferrin, PR3, neutrophil elastase, Fas, dsDNA, and mouse IgG alkaline phosphatase were from Abcam. Streptavidin Alexa Fluor 488 was from BioLegend. Live/dead stain and DHR123, CellTracker Orange, CellTrace Violet, CellMask Deep Red, and BacLight Green Bacterial Stain were from Invitrogen; Helix NP Blue was from BioLegend. Murine Fc-blocking antibody (2.4G2) was from Tonbo. PMA and DNase I were ordered from Sigma-Aldrich. Cytochalasin D was purchased from Cayman Chemical. Paraformaldehyde was from Electron Microscopy Sciences. The neutrophil elastase activity kit was purchased from Abcam. Histopaque 1119 and Histopaque 1077 were from Sigma-Aldrich; Lympholyte was from Cedarlane Laboratories. Dulbecco’s modified Eagle’s medium (DMEM) and phosphate-buffered saline (PBS) that were from Gibco and fetal bovine serum (FBS) from Atlanta Biologicals were used for all tissue culture.

Bacterial strains

All S. aureus experiments used the bacterial strain USA300 (LAC) (95). The nuc-deficient mutant and control strains were previously described (96). The agr::tet and control strain was previously described (55). The S. pneumonia bacterial strain was TIGR4 (97) and the P. aeruginosa strain was PAO1 (98). Bacteria were maintained as a −80°C stock, and S. aureus streaked onto tryptic soy agar (TSA; 2% agar), S. pneumoniae streaked onto TSA with 5% sheep blood, and P. aeruginosa streaked onto Luria-Bertani agar (LB; 2% agar) plates 2 days before each experiment. S. aureus and P. aeruginosa plates were grown overnight at 37°C, and the S. pneumoniae plate was grown overnight (37°C, 5% CO2). Single colonies of S. aureus and P. aeruginosa were transferred to tryptic soy broth (TSB) or LB broth, and liquid cultures were grown overnight at 37°C with 180 rpm of shaking. The entire S. pneumoniae plate was transferred to TSB in a sealed 15-ml conical, and liquid cultures were grown overnight at 37°C. For all in vitro experiments, overnight cultures were diluted 1:10 into non–heat-inactivated FBS for 2 hours on ice before coculture with neutrophil unless otherwise stated.

Infections

Retro-orbital infections were performed as described (99). S. aureus USA300 was streaked from frozen stocks onto TSA 2 days before infection. Overnight cultures were grown in TSB and then subcultured 1:100 into 5 ml of TSB. S. aureus was grown to the mid-exponential phase, washed, and resuspended in 100 μl of ice-cold PBS. All infections used 10- to 13-week-old female mice, which were anesthetized with intraperitoneal injection of 2,2,2-tribromoethanol diluted in PBS. Systemic infections were induced by intravenous injection of the retro-orbital sinus with 2 × 107 or 5 × 107 colony-forming units (CFU) of USA300. Mice were monitored before humane euthanasia by inhalation of CO2 at 4 dpi. For MitoTEMPO treatments, the drugs were diluted in sterile PBS and administered by intraperitoneal injection (0.7 mg/kg) 24 hours before infection and every 24 hours thereafter.

Organ harvest for CFU and neutrophil characterization

Single-cell suspensions were created from the tissue of hearts, livers, and kidneys by processing the organs through a 35-μm filter into fluorescence-activated cell sorter (FACS) media [PBS, 2% (v/v) FBS, and 0.02% NaAz]. Heart tissue was cut into small pieces using scalpels to facilitate processing of the tissue through the filter, and special care was taken to flush out the blood from the heart chambers to ensure that isolated immune cells are from the tissue. Aliquots from each organ homogenate were removed for CFU spot plating. Organ homogenates were pelleted, and the supernatant was removed to quantify NET abundance for ELISA. The remaining organ homogenate was red blood cell–lysed per the manufacturer’s instructions (BioLegend) and divided into separate aliquots in FACS media to be stained ex vivo for flow cytometry.

Neutrophil isolation

Single-cell suspensions of bone marrow were prepared from the tibias and femurs of mice. Polymorphonuclear granulocytes were isolated using density centrifugation where the neutrophils were isolated at the interface between the layers of Histopaque 1119 and Histopaque 1077. Neutrophils were rested on ice for at least 1 hour in D10 media [DMEM + 10% (v/v) FBS] and then transferred to ultralow-cluster round-bottom 96-well plates (Costar) in D10 media and incubated (37°C, 5% CO2) for 1 hour before experiments. The isolated cells were 85 to 95% neutrophils (CD11b+Ly6G+).

Bone marrow Mφ cultures

To differentiate bone marrow Mφs (BMMφs), we generated the L929 cell (European Collection of Cell Cultures) supernatant by plating 2.5 × 105 cells into a T150 flask with 50 ml of D10 media and by incubating for 12 days (37°C, 5% CO2). After 12 days, the supernatant was collected and sterile filtered.

BMMφs were derived following procedures that have been previously described (82). Bone marrow was flushed from the tibias and femurus of mice, and single-cell suspensions were created. Lympholyte separation medium (Cedarlane Laboratories) was used to isolate mononuclear cells, which were plated in a 60-mm petri dish with 6 ml of BMMφ differentiation media [D10 media with 10% (v/v) L-cell supernatant]. Cells were cultured overnight (37°C, 5% CO2), and nonadherent cells were transferred onto non–tissue culture–treated 100-mm petri dishes (1-ml cells per petri dish) with 7 ml of BMMφ differentiation media. Cells were incubated for 6 days (37°C, 5% CO2) with an additional supplementation of 5 ml of BMMφ differentiation media on day 4 to promote BMMφ differentiation. On day 7, ice-cold PBS was used to remove BMMφs from the dish. BMMφ cultures were 98% CD11b+, I-Alo, and B7.2lo.

Recombinant calprotectin

Recombinant S100A8 and S100A9 were isolated as described (100). Murine S100A8 and S100A9 in pQE32 expression vectors (a gift of C. Kerkhoff) were transformed separately into C41 (DE3) Escherichia coli cells. Cells were induced at 37°C, OD600 (optical density at 600 nm) with the addition of 1 mM isopropyl thio-β-d-galactoside and allowed to grow 4 hours after induction and then harvested via centrifugation (6.5 krpm, 20 min, 4°C). Cell pellets were combined and resuspended in lysis buffer A [50 mM tris (pH 8.0), 100 mM NaCl, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 0.5% Triton X-100, and 10 mM β-mercaptoethanol (BME)]. Once homogenized, the sample was sonicated (10 min, 50 W, 5-s on/10-s off) and centrifuged (20,000 rpm, 20 min). The supernatant was discarded, and the pellet was resuspended in lysis buffer A, sonicated, and spun down. The supernatant was discarded, and the pellet was resuspended in lysis buffer B [50 mM tris (pH 8.0), 100 mM NaCl, and 4 M guanidine hydrochloride], sonicated, and spun down. The supernatant was dialyzed into 4 liters of dialysis buffer [20 mM tris (pH 8.0) and 10 mM BME]. Then, the sample was filtered and loaded onto a SourceQ column (flow rate = 1 ml/min). After loading, the column was washed 3 times with buffer A [20 mM tris (pH 8.0) and 10 mM BME] and eluted with a gradient (10 CV, 0 → 100%) to buffer B [20 mM tris (pH 8.0), 1 M NaCl, and 10 mM BME]. Relevant fractions according to SDS–polyacrylamide gel electrophoresis (PAGE) were pooled, concentrated, and loaded onto a S75 gel filtration column. The column was eluted with 1 CV of S75 buffer [20 mM tris (pH 8.0), 100 mM NaCl, and 10 mM BME]. Relevant fractions were pooled according to SDS-PAGE, flash-frozen, and stored at −80°C. The ToxinEraser Endotoxin Removal Kit (GenScript) was used to remove lipopolysaccharide following the manufacturer’s protocol.

Flow cytometry

All data were collected using a BD LSRII flow cytometer with FACSDiva software and analyzed using FlowJo (FlowJo LLC, Ashland, OR). For all flow cytometry, samples were gated side scatter height (SSC-H) by side scatter area (SSC-A) followed by forward scatter height (FSC-H) by forward scatter area (FSC-A) to remove doublet populations. The singlet population was gated SSC-A by FSC-A to isolate the granulocyte and/or Mφ populations (representative gating in fig. S1B). The resulting cell population was then assessed for assay-specific fluorescent markers as described below.

Coculture staining

For the B6-PAD4−/− neutrophil culture, PAD4−/− neutrophils were stained in 1 μM CellTracker Orange in PBS for 20 min at room temperature and washed in D10 media before adding to unstained B6 neutrophils (representative gating to distinguish cell populations in fig. S2G). For the neutrophil-Mφ cocultures, neutrophils were stained in 5 μM CellTrace Violet, and Mφs were stained in 1 μM CellTracker Orange in serum-free DMEM for 20 min at room temperature and washed in D10 media before combining the cells into a single well at a 1:1 ratio (representative gating to distinguish cell populations in Fig. 8F).

Exogenous treatments

Cytochalasin D (10 μg/ml) was added 1 hour, rotenone (0.5 μM) 15 min, and MitoTEMPO (0.5 μM) 2 hours before stimulation with S. aureus. When treating Mφs with cytochalasin D in coculture, Mφs were pretreated and thoroughly washed in PBS before the addition of neutrophils. DNase (8 U/ml) or recombinant calprotectin trackers (25 μg/ml) were added concurrently with S. aureus.

Degranulation flow

Single-cell suspensions isolated from the tissue or isolated neutrophils and/or derived Mφs (referred to as cells for the remainder of the flow cytometry section) were stained with a live/dead dye to monitor membrane integrity 20 min before fixation. Cells were fixed in 4% paraformaldehyde at room temperature and incubated for 15 min at 4°C. Cells were pelleted, aspirated, and resuspended in Fc block for 30 min at 4°C in FACS media. Cells washed and stained with anti-CD11b, anti-Ly6G, anti-CD63 (primary), and anti-CD35 (secretory) or appropriate isotype controls in FACS media for 30 min at 4°C. Following staining, cells were washed and resuspended in FACS media for analysis. Cells were gated for live cells (Live/Dead-negative) and then neutrophils (CD11b- and Ly6G-positive) (representative gating in fig. S1B). The median fluorescence intensity (MFI) was quantified for surface CD63 and CD35 relative to staining with an isotype control antibody.

NETosis flow

Cells were live/dead-stained as described above except Helix NP Blue (2.5 nM) was also introduced to the cultures. Cells were fixed, blocked, and stained for neutrophils (anti-CD11b and anti-Ly6G) as described above. While being stained for neutrophils, cells were also stained with anti-MPO and anti-H3Cit antibodies. Cells were washed and stained with fluorescent anti-rabbit IgG and streptavidin in FACS media for 30 min at 4°C. Following staining, cells were washed and resuspended in FACS media for analysis. Cells were gated for neutrophils and then live or dead cells. Neutrophils with permeabilized cell membranes that are positive for extracellular dsDNA, MPO, and H3Cit were defined as having undergone suicidal NETosis, and neutrophils positive for extracellular dsDNA, MPO, and H3Cit and with intact cell membranes were defined as having undergone vital NETosis (representative gating in fig. S2A). The percentage of neutrophils undergoing vital or suicidal NETosis was quantified relative to the total number of neutrophils.

Total ROS or mitochondrial O2 flow

Cells were live/dead-stained as described in the “Degranulation flow” section except DHR123 (3 μM) was also introduced to the cultures to quantify total ROS production, or MitoSOX red (5 μM) and MitoTracker deep red (500 nM) were introduced to quantify mitochondrial O2 production. Cells were fixed, blocked, and stained for neutrophils (anti-CD11b and anti-Ly6G) as described in the “Degranulation flow” section. Following staining, cells were washed and resuspended in FACS media for analysis. Cells were gated for live cells and then neutrophils (representative gating in fig. S1B). For total ROS production, the DHR123 MFI was quantified relative to unstimulated neutrophils (in vitro assays) or mock-treated mice (in vivo infections). For mitochondrial O2, MitoSOX MFI was normalized to MitoTracker MFI.

Phagocytosis

For in vitro assays, BacLight-labeled bacteria were used, and, for in vivo infections, a fluorescent strain of S. aureus (pSarA_sfGFP) (65) was used to quantify internalized bacteria in vivo. Cells were live/dead-stained, fixed, blocked, and stained for neutrophils (anti-CD11b and anti-Ly6G) as described in the “Degranulation flow” section. If phagocytosis is being quantified in cocultures, then neutrophils and Mφs were distinguished by the staining described in the “Coculture staining” section. If phagocytosis is being quantified in Mφs in vivo, then Mφs were identified as CD11b+F4/80+. Following staining, cells were washed and resuspended in FACS media for analysis. Cells were gated for live cells and then neutrophils (representative gating in fig. S1B) or Mφs. The MFI was quantified for bacteria per cell, and background fluorescence was subtracted using unstimulated neutrophils or Mφs (in vitro assays) or mock-treated mice (in vivo infections).

AMP transfer

Cells were live/dead-stained, fixed, and blocked as described in the “Degranulation flow” section. Neutrophils and Mφs were distinguished by the staining described in the “Coculture staining” section. Following block, cells were washed and stained with anti-lactoferrin, anti-PR3, anti-elastase, or isotype control antibodies in permeabilization buffer (PBS + 0.05% saponin + 0.5% bovine serum albumin) for 30 min at 4°C, washed, and stained with anti-rabbit IgG in permeabilization buffer for 30 min at 4°C. Following all staining, cells were washed and resuspended in FACS media for analysis. Cells were gated for live cells and then neutrophils (representative gating in fig. S1B) or Mφs. The MFI was quantified for intracellular lactoferrin, PR3, and elastase relative to staining with an isotype control antibody.

Confocal imaging

For NETosis imaging, neutrophils were stained in with CellMask Deep Red in PBS for 20 min at room temperature and washed in D10 media before plating. Neutrophils were incubated for 2 hours (37°C, 5% CO2) on glass-bottom petri dishes (MatTek Corporation, Ashland, MA) in phenol red–free D10 to allow cells to properly attach to the dish. For NETosis imaging, S. aureus was stained with BacLight Green for 30 min on ice and added to the dish at a multiplicity of infection (MOI) of 1. Helix NP Blue was added 20 min before fixation to stain for extracellular DNA (NET structures). For superoxide imaging, unstained S. aureus was added to the dish at an MOI of 1. MitoTracker Deep Red and MitoSOX Red were added 20 min before fixation to stain for mitochondrial structures and superoxide. Cells were fixed in 4% paraformaldehyde at room temperature and incubated for 15 min at 4°C. Dishes were aspirated, and samples were preserved using the ProLong Gold Antifade Mountant. All microscopy was done using a Zeiss 880 microscope with AiryScan and Zeiss Zen Software. Images were analyzed using ImageJ.

NET DNA ELISA

Vinyl 96-well plates were charged using 0.01% poly-l-lysine solution (Sigma-Aldrich). For samples, wells were coated with anti-MPO or anti-neutrophil elastase antibody, and for the DNA standard, dsDNA (Sigma-Aldrich) was titrated using fourfold dilutions starting at 10 mg/ml. DNA in the wells was detected using an anti-dsDNA antibody (mouse IgG) followed by a secondary anti-mouse antibody conjugated with alkaline phosphatase and p-nitrophenyl phosphate (1 mg/ml) (Sigma-Aldrich). Abundance of NET DNA was quantified using a BioTek plater reader (OD = 405λ). Samples and standards were read in duplicate, and DNA abundance was quantified relative to the standard.

Bacterial killing assay

Neutrophils, Mφs, or neutrophil-Mφ (1:1) cocultures were cultured with bacteria at an MOI of 1 (20,000 CFU per 20,000 immune cells) in D10 (37°C, 5% CO2). After 30 min, 2, 6, 12, and 24 hours, samples were serially diluted and spot-plated onto TSA. Percent growth was quantified by dividing the CFU of the bacteria–immune cell cultures by the bacteria alone cultures.

NET isolation

NETs were isolated as previously described (61). Briefly, neutrophils were transferred to ultralow-cluster flat round-bottom six-well plates (Costar) in 0.75 ml of D10 media (1 × 106 cells per well) and incubated (37°C, 5% CO2) for 1 hour. To induce NETosis, neutrophils were stimulated with PMA (100 nM) and incubated (37°C, 5% CO2) for 4 hours. To induce apoptosis, neutrophils were stimulated with an agonistic anti-Fas antibody (100 ng/ml) and incubated (37°C, 5% CO2) for 16 hours. In the final 15 min, the restriction enzyme Alu I (New England Biolabs) was added to the neutrophil cultures (4 U/ml). The supernatant was collected and centrifuged (300g) for 5 min at 4°C to remove whole cells and debris. A fraction of the supernatant was stained with Helix NP, and abundance of fluorescent NET structures was quantified in a plate reader to assure equal concentrations of NETs. Overnight S. aureus cultures were diluted 1:10 into 500 μl of the NET-rich supernatants and placed on ice for 15 min.

Neutrophil elastase activity assay

Fluorescently labeled neutrophils and Mφs (as described in the “Coculture staining” section) in coculture were stimulated with S. aureus (MOI = 10). After 2 hours, immune cells were pelleted and resuspended in ice-cold FACS media for fluorescence-activated cell sorting. Isolated immune cells were pelleted and resuspended in lysis buffer (1% IGEPAL + protease inhibitors). Lysates were held on ice for 5 min followed by the removal of particulate material by centrifugation at 12,000g for 10 min at 4°C. Neutrophil elastase activity was detected per the manufacturer’s instructions (Abcam) using a BioTek Cytation 5 fluorescence plate reader.

Nuclease activity assay

In rhodamine-free D10 media, 5 × 106 CFU of bacteria were stimulated with 30 μM calprotectin in a round-bottom 96-well plate (37°C, 5% CO2) to stimulate the Sae sensory system. At appropriate time points, half of the supernatant from the bacteria was transferred to a flat-bottom, black-wall, 96-well plate containing calf thymus DNA stained with Helix NP in PBS (500 ng/ml). A titration of DNase I was used a standard to quantify relative nuclease activity. Fluorescence intensity (excitation: 440 ± 10, emission: 480 ± 10) was read every 15 min in a plate reader at 37°C with shaking. The decay rate of fluorescence was normalized to account for photobleaching (labeled DNA + supernatant from wells containing no bacteria but stimulated with calprotectin), and relative activity was quantified by fitting the kinetic curves to the DNase I standard. The presence of calprotectin in supernatants from wells lacking bacteria had no effect on DNA degradation. The remaining bacteria in the first plate were resuspended, and OD600 was quantified in a plate reader to normalize nuclease activity to bacterial concentrations.

Statistics

Specific statistical details for each experiment can be found in the corresponding figure legends. Error bars for all experiments represent SEM across mice. A minimum of three experimental replicates were performed for each assay, and the specific number of replicates is noted in the corresponding figure legend. All P values were calculated using a two-way analysis of variance (ANOVA) (with Sidak’s multiple comparisons test or Tukey multiple comparisons test), unpaired t test, or log-rank (Mantel-Cox) test when applicable. Statistical work was performed using Prism 6 software (GraphPad), and significance is indicated on the graphs as follows: *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001; ns, not significant.

Acknowledgments

We thank A. Horswill, V. Torres, J. Cassat, J. Rosch, and A. Battistoni for providing bacterial strains and C. Kerkhoff for the S100A8 and S100A9 expression vectors. We also thank all the members of the Skaar lab who provided feedback on the project and paper. Funding: This work was supported by NIH R01 AI069233 (to E.P.S.), R01 AI073843 (to E.P.S.), R01 AI101171 (to E.P.S. and W.J.C.), and a grant from the Edward P. Evans Foundation (to E.P.S. and W.J.C.) and funds from Incyte Pharmaceuticals. A.J.M. was supported by the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship F32HL144081. Flow cytometry experiments were performed in the VUMC Flow Cytometry Shared Resource, which is supported by the Vanderbilt Ingram Cancer Center (P30 CA68485) and the Vanderbilt Digestive Disease Research Center (DK058404). Confocal imaging was performed in Vanderbilt Cell Imaging Shared Resource (supported by NIH grants CA68485, DK20593, DK58404, DK59637, and EY08126). Author contributions: A.J.M. and E.P.S. designed the experiments and wrote the manuscript with input from the co-authors. A.J.M. performed most of the experiments described in this study. J.M.M. assisted in harvesting neutrophils for the in vitro studies and isolating cells and bacteria from the organs following infections. C.N.M. and W.J.C. generated the purification protocol and produced the recombinant murine calprotectin. Competing interests: The authors declare that they have no competing interests. Data and materials availability: All data needed to evaluate the conclusions in the paper are present in the paper and/or the Supplementary Materials.

Supplementary Materials

This PDF file includes:

Figs. S1 to S9

View/request a protocol for this paper from Bio-protocol.

REFERENCES AND NOTES

  • 1.Klein M., Wang A., Infective endocarditis. J. Intensive Care Med. 31, 151–163 (2016). [DOI] [PubMed] [Google Scholar]
  • 2.Anderson D. J., Moehring R. W., Sloane R., Schmader K. E., Weber D. J., Fowler V. G. Jr., Smathers E., Sexton D. J., Bloodstream infections in community hospitals in the 21st century: A multicenter cohort study. PLOS ONE 9, e91713 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Collins L. V., Kristian S. A., Weidenmaier C., Faigle M., Van Kessel K. P., Van Strijp J. A., Gotz F., Neumeister B., Peschel A., Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice. J. Infect. Dis. 186, 214–219 (2002). [DOI] [PubMed] [Google Scholar]
  • 4.Green J. N., Kettle A. J., Winterbourn C. C., Protein chlorination in neutrophil phagosomes and correlation with bacterial killing. Free Radic. Biol. Med. 77, 49–56 (2014). [DOI] [PubMed] [Google Scholar]
  • 5.Hampton M. B., Winterbourn C. C., Modification of neutrophil oxidant production with diphenyleneiodonium and its effect on bacterial killing. Free Radic. Biol. Med. 18, 633–639 (1995). [DOI] [PubMed] [Google Scholar]
  • 6.Peschel A., Otto M., Jack R. W., Kalbacher H., Jung G., Gotz F., Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274, 8405–8410 (1999). [DOI] [PubMed] [Google Scholar]
  • 7.Sieprawska-Lupa M., Mydel P., Krawczyk K., Wojcik K., Puklo M., Lupa B., Suder P., Silberring J., Reed M., Pohl J., Shafer W., McAleese F., Foster T., Travis J., Potempa J., Degradation of human antimicrobial peptide LL-37 by Staphylococcus aureus-derived proteinases. Antimicrob. Agents Chemother. 48, 4673–4679 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Pilsczek F. H., Salina D., Poon K. K., Fahey C., Yipp B. G., Sibley C. D., Robbins S. M., Green F. H., Surette M. G., Sugai M., Bowden M. G., Hussain M., Zhang K., Kubes P., A novel mechanism of rapid nuclear neutrophil extracellular trap formation in response to Staphylococcus aureus. J. Immunol. 185, 7413–7425 (2010). [DOI] [PubMed] [Google Scholar]
  • 9.Brinkmann V., Reichard U., Goosmann C., Fauler B., Uhlemann Y., Weiss D. S., Weinrauch Y., Zychlinsky A., Neutrophil extracellular traps kill bacteria. Science 303, 1532–1535 (2004). [DOI] [PubMed] [Google Scholar]
  • 10.Berends E. T., Horswill A. R., Haste N. M., Monestier M., Nizet V., von Kockritz-Blickwede M., Nuclease expression by Staphylococcus aureus facilitates escape from neutrophil extracellular traps. J. Innate Immun. 2, 576–586 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.D’Cruz A. A., Speir M., Bliss-Moreau M., Dietrich S., Wang S., Chen A. A., Gavillet M., Al-Obeidi A., Lawlor K. E., Vince J. E., Kelliher M. A., Hakem R., Pasparakis M., Williams D. A., Ericsson M., Croker B. A., The pseudokinase MLKL activates PAD4-dependent NET formation in necroptotic neutrophils. Sci. Signal. 11, eaao1716 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Bhattacharya M., Berends E. T. M., Zheng X., Hill P. J., Chan R., Torres V. J., Wozniak D. J., Leukocidins and the nuclease Nuc prevent neutrophil mediated killing of Staphylococcus aureus biofilms. Infect. Immun. 88, (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Hunter M. J., Chazin W. J., High level expression and dimer characterization of the S100 EF-hand proteins, migration inhibitory factor-related proteins 8 and 14. J. Biol. Chem. 273, 12427–12435 (1998). [DOI] [PubMed] [Google Scholar]
  • 14.Propper C., Huang X., Roth J., Sorg C., Nacken W., Analysis of the MRP8-MRP14 protein-protein interaction by the two-hybrid system suggests a prominent role of the C-terminal domain of S100 proteins in dimer formation. J. Biol. Chem. 274, 183–188 (1999). [DOI] [PubMed] [Google Scholar]
  • 15.Edgeworth J., Gorman M., Bennett R., Freemont P., Hogg N., Identification of p8,14 as a highly abundant heterodimeric calcium binding protein complex of myeloid cells. J. Biol. Chem. 266, 7706–7713 (1991). [PubMed] [Google Scholar]
  • 16.Corbin B. D., Seeley E. H., Raab A., Feldmann J., Miller M. R., Torres V. J., Anderson K. L., Dattilo B. M., Dunman P. M., Gerads R., Caprioli R. M., Nacken W., Chazin W. J., Skaar E. P., Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319, 962–965 (2008). [DOI] [PubMed] [Google Scholar]
  • 17.Kehl-Fie T. E., Zhang Y., Moore J. L., Farrand A. J., Hood M. I., Rathi S., Chazin W. J., Caprioli R. M., Skaar E. P., MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect. Immun. 81, 3395–3405 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Cornish C. J., Devery J. M., Poronnik P., Lackmann M., Cook D. I., Geczy C. L., S100 protein CP-10 stimulates myeloid cell chemotaxis without activation. J. Cell. Physiol. 166, 427–437 (1996). [DOI] [PubMed] [Google Scholar]
  • 19.Lackmann M., Cornish C. J., Simpson R. J., Moritz R. L., Geczy C. L., Purification and structural analysis of a murine chemotactic cytokine (CP-10) with sequence homology to S100 proteins. J. Biol. Chem. 267, 7499–7504 (1992). [PubMed] [Google Scholar]
  • 20.Ghavami S., Rashedi I., Dattilo B. M., Eshraghi M., Chazin W. J., Hashemi M., Wesselborg S., Kerkhoff C., Los M., S100A8/A9 at low concentration promotes tumor cell growth via RAGE ligation and MAP kinase-dependent pathway. J. Leukoc. Biol. 83, 1484–1492 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Vogl T., Tenbrock K., Ludwig S., Leukert N., Ehrhardt C., van Zoelen M. A., Nacken W., Foell D., van der Poll T., Sorg C., Roth J., Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat. Med. 13, 1042–1049 (2007). [DOI] [PubMed] [Google Scholar]
  • 22.Juttukonda L. J., Berends E. T. M., Zackular J. P., Moore J. L., Stier M. T., Zhang Y., Schmitz J. E., Beavers W. N., Wijers C. D., Gilston B. A., Kehl-Fie T. E., Atkinson J., Washington M. K., Peebles R. S., Chazin W. J., Torres V. J., Caprioli R. M., Skaar E. P., Dietary manganese promotes staphylococcal infection of the heart. Cell Host Microbe 22, 531–542.e8 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Flannagan R. S., Kuiack R. C., McGavin M. J., Heinrichs D. E., Staphylococcus aureus uses the GraXRS regulatory system to sense and adapt to the acidified phagolysosome in macrophages. MBio 9, e01143-18 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Grayczyk J. P., Harvey C. J., Laczkovich I., Alonzo F. III, A lipoylated metabolic protein released by Staphylococcus aureus suppresses macrophage activation. Cell Host Microbe 22, 678–687 e679 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Fang F. C., Antimicrobial reactive oxygen and nitrogen species: Concepts and controversies. Nat. Rev. Microbiol. 2, 820–832 (2004). [DOI] [PubMed] [Google Scholar]
  • 26.Slauch J. M., How does the oxidative burst of macrophages kill bacteria? Still an open question. Mol. Microbiol. 80, 580–583 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Botella H., Peyron P., Levillain F., Poincloux R., Poquet Y., Brandli I., Wang C., Tailleux L., Tilleul S., Charrière G. M., Waddell S. J., Foti M., Lugo-Villarino G., Gao Q., Maridonneau-Parini I., Butcher P. D., Castagnoli P. R., Gicquel B., de Chastellier C., Neyrolles O., Mycobacterial p1-type ATPases mediate resistance to zinc poisoning in human macrophages. Cell Host Microbe 10, 248–259 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Wagner D., Maser J., Lai B., Cai Z., Barry C. E. III, Bentrup K. H. Z., Russell D. G., Bermudez L. E., Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis-containing phagosomes indicates pathogen-induced microenvironments within the host cell’s endosomal system. J. Immunol. 174, 1491–1500 (2005). [DOI] [PubMed] [Google Scholar]
  • 29.Lukacs G. L., Rotstein O. D., Grinstein S., Phagosomal acidification is mediated by a vacuolar-type H(+)-ATPase in murine macrophages. J. Biol. Chem. 265, 21099–21107 (1990). [PubMed] [Google Scholar]
  • 30.Lukacs G. L., Rotstein O. D., Grinstein S., Determinants of the phagosomal pH in macrophages. In situ assessment of vacuolar H(+)-ATPase activity, counterion conductance, and H+ "leak". J. Biol. Chem. 266, 24540–24548 (1991). [PubMed] [Google Scholar]
  • 31.Flannagan R. S., Heit B., Heinrichs D. E., Intracellular replication of Staphylococcus aureus in mature phagolysosomes in macrophages precedes host cell death, and bacterial escape and dissemination. Cell. Microbiol. 18, 514–535 (2016). [DOI] [PubMed] [Google Scholar]
  • 32.Surewaard B. G., Deniset J. F., Zemp F. J., Amrein M., Otto M., Conly J., Omri A., Yates R. M., Kubes P., Identification and treatment of the Staphylococcus aureus reservoir in vivo. J. Exp. Med. 213, 1141–1151 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Byrd T. F., Horwitz M. A., Lactoferrin inhibits or promotes Legionella pneumophila intracellular multiplication in nonactivated and interferon gamma-activated human monocytes depending upon its degree of iron saturation. Iron-lactoferrin and nonphysiologic iron chelates reverse monocyte activation against Legionella pneumophila. J. Clin. Invest. 88, 1103–1112 (1991). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Miyakawa Y., Ratnakar P., Rao A. G., Costello M. L., Mathieu-Costello O., Lehrer R. I., Catanzaro A., In vitro activity of the antimicrobial peptides human and rabbit defensins and porcine leukocyte protegrin against Mycobacterium tuberculosis. Infect. Immun. 64, 926–932 (1996). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Silva M. T., Silva M. N., Appelberg R., Neutrophil-macrophage cooperation in the host defence against mycobacterial infections. Microb. Pathog. 6, 369–380 (1989). [DOI] [PubMed] [Google Scholar]
  • 36.Tan B. H., Meinken C., Bastian M., Bruns H., Legaspi A., Ochoa M. T., Krutzik S. R., Bloom B. R., Ganz T., Modlin R. L., Stenger S., Macrophages acquire neutrophil granules for antimicrobial activity against intracellular pathogens. J. Immunol. 177, 1864–1871 (2006). [DOI] [PubMed] [Google Scholar]
  • 37.Kim M. H., Granick J. L., Kwok C., Walker N. J., Borjesson D. L., Curry F. R., Miller L. S., Simon S. I., Neutrophil survival and c-kit+-progenitor proliferation in Staphylococcus aureus-infected skin wounds promote resolution. Blood 117, 3343–3352 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Cho J. S., Guo Y., Ramos R. I., Hebroni F., Plaisier S. B., Xuan C., Granick J. L., Matsushima H., Takashima A., Iwakura Y., Cheung A. L., Cheng G., Lee D. J., Simon S. I., Miller L. S., Neutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLOS Pathog. 8, e1003047 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Asai A., Tsuda Y., Kobayashi M., Hanafusa T., Herndon D. N., Suzuki F., Pathogenic role of macrophages in intradermal infection of methicillin-resistant Staphylococcus aureus in thermally injured mice. Infect. Immun. 78, 4311–4319 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Feuerstein R., Seidl M., Prinz M., Henneke P., MyD88 in macrophages is critical for abscess resolution in staphylococcal skin infection. J. Immunol. 194, 2735–2745 (2015). [DOI] [PubMed] [Google Scholar]
  • 41.Lee J. S., Sohn J. Y., Jung H. D., Kim S. T., Lee K. G., Kang H. J., Pace of macrophage recruitment during different stages of soft tissue infection: Semi-quantitative evaluation by in vivo magnetic resonance imaging. Eur. Radiol. 18, 2033–2039 (2008). [DOI] [PubMed] [Google Scholar]
  • 42.Brandt S. L., Klopfenstein N., Wang S., Winfree S., McCarthy B. P., Territo P. R., Miller L., Serezani C. H., Macrophage-derived LTB4 promotes abscess formation and clearance of Staphylococcus aureus skin infection in mice. PLOS Pathog. 14, e1007244 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.Duthie E. S., Lorenz L. L., Staphylococcal coagulase; mode of action and antigenicity. J. Gen. Microbiol. 6, 95–107 (1952). [DOI] [PubMed] [Google Scholar]
  • 44.Pollitt E. J. G., Szkuta P. T., Burns N., Foster S. J., Staphylococcus aureus infection dynamics. PLOS Pathog. 14, e1007112 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Metzler K. D., Goosmann C., Lubojemska A., Zychlinsky A., Papayannopoulos V., A myeloperoxidase-containing complex regulates neutrophil elastase release and actin dynamics during NETosis. Cell Rep. 8, 883–896 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Papayannopoulos V., Metzler K. D., Hakkim A., Zychlinsky A., Neutrophil elastase and myeloperoxidase regulate the formation of neutrophil extracellular traps. J. Cell Biol. 191, 677–691 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Gavillet M., Martinod K., Renella R., Harris C., Shapiro N. I., Wagner D. D., Williams D. A., Flow cytometric assay for direct quantification of neutrophil extracellular traps in blood samples. Am. J. Hematol. 90, 1155–1158 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Lee K. H., Cavanaugh L., Leung H., Yan F., Ahmadi Z., Chong B. H., Passam F., Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis. Int. J. Lab. Hematol. 40, 392–399 (2018). [DOI] [PubMed] [Google Scholar]
  • 49.Masuda S., Shimizu S., Matsuo J., Nishibata Y., Kusunoki Y., Hattanda F., Shida H., Nakazawa D., Tomaru U., Atsumi T., Ishizu A., Measurement of NET formation in vitro and in vivo by flow cytometry. Cytometry A 91, 822–829 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 50.Perdomo J., Leung H. H. L., Ahmadi Z., Yan F., Chong J. J. H., Passam F. H., Chong B. H., Neutrophil activation and NETosis are the major drivers of thrombosis in heparin-induced thrombocytopenia. Nat. Commun. 10, 1322 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Zharkova O., Tay S. H., Lee H. Y., Shubhita T., Ong W. Y., Lateef A., MacAry P. A., Lim L. H. K., Connolly J. E., Fairhurst A. M., A flow cytometry-based assay for high-throughput detection and quantification of neutrophil extracellular traps in mixed cell populations. Cytometry A 95, 268–278 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Olson M. E., Nygaard T. K., Ackermann L., Watkins R. L., Zurek O. W., Pallister K. B., Griffith S., Kiedrowski M. R., Flack C. E., Kavanaugh J. S., Kreiswirth B. N., Horswill A. R., Voyich J. M., Staphylococcus aureus nuclease is an SaeRS-dependent virulence factor. Infect. Immun. 81, 1316–1324 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53.Cho H., Jeong D. W., Liu Q., Yeo W. S., Vogl T., Skaar E. P., Chazin W. J., Bae T., Calprotectin increases the activity of the SaeRS two component system and murine mortality during Staphylococcus aureus infections. PLOS Pathog. 11, e1005026 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Hemmers S., Teijaro J. R., Arandjelovic S., Mowen K. A., PAD4-mediated neutrophil extracellular trap formation is not required for immunity against influenza infection. PLOS ONE 6, e22043 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Benson M. A., Lilo S., Wasserman G. A., Thoendel M., Smith A., Horswill A. R., Fraser J., Novick R. P., Shopsin B., Torres V. J., Staphylococcus aureus regulates the expression and production of the staphylococcal superantigen-like secreted proteins in a Rot-dependent manner. Mol. Microbiol. 81, 659–675 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Apel F., Andreeva L., Knackstedt L. S., Streeck R., Frese C. K., Goosmann C., Hopfner K. P., Zychlinsky A., The cytosolic DNA sensor cGAS recognizes neutrophil extracellular traps. Sci. Signal. 14, eaax7942 (2021). [DOI] [PubMed] [Google Scholar]
  • 57.Lood C., Blanco L. P., Purmalek M. M., Carmona-Rivera C., De Ravin S. S., Smith C. K., Malech H. L., Ledbetter J. A., Elkon K. B., Kaplan M. J., Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22, 146–153 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Sule G., Abuaita B. H., Steffes P. A., Fernandes A. T., Estes S. K., Dobry C., Pandian D., Gudjonsson J. E., Kahlenberg J. M., O’Riordan M. X., Knight J. S., Endoplasmic reticulum stress sensor IRE1α propels neutrophil hyperactivity in lupus. J. Clin. Invest. 131, e137866 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59.Fuchs T. A., Abed U., Goosmann C., Hurwitz R., Schulze I., Wahn V., Weinrauch Y., Brinkmann V., Zychlinsky A., Novel cell death program leads to neutrophil extracellular traps. J. Cell Biol. 176, 231–241 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Douda D. N., Khan M. A., Grasemann H., Palaniyar N., SK3 channel and mitochondrial ROS mediate NADPH oxidase-independent NETosis induced by calcium influx. Proc. Natl. Acad. Sci. U.S.A. 112, 2817–2822 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Barrientos L., Marin-Esteban V., de Chaisemartin L., Le-Moal V. L., Sandre C., Bianchini E., Nicolas V., Pallardy M., Chollet-Martin S., An improved strategy to recover large fragments of functional human neutrophil extracellular traps. Front. Immunol. 4, 166 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Schneewind O., Model P., Fischetti V. A., Sorting of protein A to the staphylococcal cell wall. Cell 70, 267–281 (1992). [DOI] [PubMed] [Google Scholar]
  • 63.Peterson P. K., Verhoef J., Sabath L. D., Quie P. G., Effect of protein A on staphylococcal opsonization. Infect. Immun. 15, 760–764 (1977). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Stemerding A. M., Kohl J., Pandey M. K., Kuipers A., Leusen J. H., Boross P., Nederend M., Vidarsson G., Weersink A. Y., van de Winkel J. G., van Kessel K. P., van Strijp J. A., Staphylococcus aureus formyl peptide receptor-like 1 inhibitor (FLIPr) and its homologue FLIPr-like are potent FcγR antagonists that inhibit IgG-mediated effector functions. J. Immunol. 191, 353–362 (2013). [DOI] [PubMed] [Google Scholar]
  • 65.Ryan D. J., Patterson N. H., Putnam N. E., Wilde A. D., Weiss A., Perry W. J., Cassat J. E., Skaar E. P., Caprioli R. M., Spraggins J. M., MicroLESA: Integrating autofluorescence microscopy, in situ micro-digestions, and liquid extraction surface analysis for high spatial resolution targeted proteomic studies. Anal. Chem. 91, 7578–7585 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Beiter K., Wartha F., Albiger B., Normark S., Zychlinsky A., Henriques-Normark B., An endonuclease allows Streptococcus pneumoniae to escape from neutrophil extracellular traps. Curr. Biol. 16, 401–407 (2006). [DOI] [PubMed] [Google Scholar]
  • 67.Halverson T. W., Wilton M., Poon K. K., Petri B., Lewenza S., DNA is an antimicrobial component of neutrophil extracellular traps. PLOS Pathog. 11, e1004593 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Cesaro A., Anceriz N., Plante A., Page N., Tardif M. R., Tessier P. A., An inflammation loop orchestrated by S100A9 and calprotectin is critical for development of arthritis. PLOS ONE 7, e45478 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Tydén H., Lood C., Gullstrand B., Jonsen A., Nived O., Sturfelt G., Truedsson L., Ivars F., Leanderson T., Bengtsson A. A., Increased serum levels of S100A8/A9 and S100A12 are associated with cardiovascular disease in patients with inactive systemic lupus erythematosus. Rheumatology 52, 2048–2055 (2013). [DOI] [PubMed] [Google Scholar]
  • 70.Hermani A., De Servi B., Medunjanin S., Tessier P. A., Mayer D., S100A8 and S100A9 activate MAP kinase and NF-κB signaling pathways and trigger translocation of RAGE in human prostate cancer cells. Exp. Cell Res. 312, 184–197 (2006). [DOI] [PubMed] [Google Scholar]
  • 71.Hiratsuka S., Watanabe A., Aburatani H., Maru Y., Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis. Nat. Cell Biol. 8, 1369–1375 (2006). [DOI] [PubMed] [Google Scholar]
  • 72.Ichikawa M., Williams R., Wang L., Vogl T., Srikrishna G., S100A8/A9 activate key genes and pathways in colon tumor progression. Mol. Cancer Res. 9, 133–148 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Overmyer K. A., Shishkova E., Miller I. J., Balnis J., Bernstein M. N., Peters-Clarke T. M., Meyer J. G., Quan Q., Muehlbauer L. K., Trujillo E. A., He Y., Chopra A., Chieng H. C., Tiwari A., Judson M. A., Paulson B., Brademan D. R., Zhu Y., Serrano L. R., Linke V., Drake L. A., Adam A. P., Schwartz B. S., Singer H. A., Swanson S., Mosher D. F., Stewart R., Coon J. J., Jaitovich A., Large-scale multi-omic analysis of COVID-19 severity. Cell Syst. 12, 29–40.e7 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Swindell W. R., Johnston A., Xing X., Little A., Robichaud P., Voorhees J. J., Fisher G., Gudjonsson J. E., Robust shifts in S100a9 expression with aging: A novel mechanism for chronic inflammation. Sci. Rep. 3, 1215 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 75.Adhikari R. P., Novick R. P., Regulatory organization of the staphylococcal sae locus. Microbiology 154, 949–959 (2008). [DOI] [PubMed] [Google Scholar]
  • 76.Geiger T., Goerke C., Mainiero M., Kraus D., Wolz C., The virulence regulator Sae of Staphylococcus aureus: Promoter activities and response to phagocytosis-related signals. J. Bacteriol. 190, 3419–3428 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Berthier S., Paclet M. H., Lerouge S., Roux F., Vergnaud S., Coleman A. W., Morel F., Changing the conformation state of cytochrome b558 initiates NADPH oxidase activation: MRP8/MRP14 regulation. J. Biol. Chem. 278, 25499–25508 (2003). [DOI] [PubMed] [Google Scholar]
  • 78.Jia J., Arif A., Terenzi F., Willard B., Plow E. F., Hazen S. L., Fox P. L., Target-selective protein S-nitrosylation by sequence motif recognition. Cell 159, 623–634 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.de Seny D., Bianchi E., Baiwir D., Cobraiville G., Collin C., Deliège M., Kaiser M. J., Mazzucchelli G., Hauzeur J.-P., Delvenne P., Malaise M. G., Proteins involved in the endoplasmic reticulum stress are modulated in synovitis of osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis, and correlate with the histological inflammatory score. Sci. Rep. 10, 14159 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Li T. T., Jia L. X., Zhang W. M., Li X. Y., Zhang J., Li Y. L., Li H. H., Qi Y. F., Du J., Endoplasmic reticulum stress in bone marrow-derived cells prevents acute cardiac inflammation and injury in response to angiotensin II. Cell Death Dis. 7, e2258 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Lappann M., Danhof S., Guenther F., Olivares-Florez S., Mordhorst I. L., Vogel U., In vitro resistance mechanisms of Neisseria meningitidis against neutrophil extracellular traps. Mol. Microbiol. 89, 433–449 (2013). [DOI] [PubMed] [Google Scholar]
  • 82.Monteith A. J., Kang S., Scott E., Hillman K., Rajfur Z., Jacobson K., Costello M. J., Vilen B. J., Defects in lysosomal maturation facilitate the activation of innate sensors in systemic lupus erythematosus. Proc. Natl. Acad. Sci. U.S.A. 113, E2142–E2151 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83.Gresham H. D., Lowrance J. H., Caver T. E., Wilson B. S., Cheung A. L., Lindberg F. P., Survival of Staphylococcus aureus inside neutrophils contributes to infection. J. Immunol. 164, 3713–3722 (2000). [DOI] [PubMed] [Google Scholar]
  • 84.Lehar S. M., Pillow T., Xu M., Staben L., Kajihara K. K., Vandlen R., DePalatis L., Raab H., Hazenbos W. L., Morisaki J. H., Kim J., Park S., Darwish M., Lee B. C., Hernandez H., Loyet K. M., Lupardus P., Fong R., Yan D., Chalouni C., Luis E., Khalfin Y., Plise E., Cheong J., Lyssikatos J. P., Strandh M., Koefoed K., Andersen P. S., Flygare J. A., Wah Tan M., Brown E. J., Mariathasan S., Novel antibody-antibiotic conjugate eliminates intracellular S. aureus. Nature 527, 323–328 (2015). [DOI] [PubMed] [Google Scholar]
  • 85.Rice W. G., Weiss S. J., Regulation of proteolysis at the neutrophil-substrate interface by secretory leukoprotease inhibitor. Science 249, 178–181 (1990). [DOI] [PubMed] [Google Scholar]
  • 86.Senior R. M., Campbell E. J., Landis J. A., Cox F. R., Kuhn C., Koren H. S., Elastase of U-937 monocytelike cells: Comparisons with elastases derived from human monocytes and neutrophils and murine macrophagelike cells. J. Clin. Invest. 69, 384–393 (1982). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Weiss S. J., Tissue destruction by neutrophils. N. Engl. J. Med. 320, 365–376 (1989). [DOI] [PubMed] [Google Scholar]
  • 88.Weiss S. J., Curnutte J. T., Regiani S., Neutrophil-mediated solubilization of the subendothelial matrix: Oxidative and nonoxidative mechanisms of proteolysis used by normal and chronic granulomatous disease phagocytes. J. Immunol. 136, 636–641 (1986). [PubMed] [Google Scholar]
  • 89.Weiss S. J., Regiani S., Neutrophils degrade subendothelial matrices in the presence of alpha-1-proteinase inhibitor. Cooperative use of lysosomal proteinases and oxygen metabolites. J. Clin. Invest. 73, 1297–1303 (1984). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 90.Fadok V. A., McDonald P. P., Bratton D. L., Henson P. M., Regulation of macrophage cytokine production by phagocytosis of apoptotic and post-apoptotic cells. Biochem. Soc. Trans. 26, 653–656 (1998). [DOI] [PubMed] [Google Scholar]
  • 91.Lauber K., Blumenthal S. G., Waibel M., Wesselborg S., Clearance of apoptotic cells: Getting rid of the corpses. Mol. Cell 14, 277–287 (2004). [DOI] [PubMed] [Google Scholar]
  • 92.Fadok V. A., Bratton D. L., Guthrie L., Henson P. M., Differential effects of apoptotic versus lysed cells on macrophage production of cytokines: Role of proteases. J. Immunol. 166, 6847–6854 (2001). [DOI] [PubMed] [Google Scholar]
  • 93.Stern M., Savill J., Haslett C., Human monocyte-derived macrophage phagocytosis of senescent eosinophils undergoing apoptosis. Mediation by alpha v beta 3/CD36/thrombospondin recognition mechanism and lack of phlogistic response. Am. J. Pathol. 149, 911–921 (1996). [PMC free article] [PubMed] [Google Scholar]
  • 94.Nakazawa D., Shida H., Kusunoki Y., Miyoshi A., Nishio S., Tomaru U., Atsumi T., Ishizu A., The responses of macrophages in interaction with neutrophils that undergo NETosis. J. Autoimmun. 67, 19–28 (2016). [DOI] [PubMed] [Google Scholar]
  • 95.Tenover F. C., McDougal L. K., Goering R. V., Killgore G., Projan S. J., Patel J. B., Dunman P. M., Characterization of a strain of community-associated methicillin-resistant Staphylococcus aureus widely disseminated in the United States. J. Clin. Microbiol. 44, 108–118 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Kiedrowski M. R., Kavanaugh J. S., Malone C. L., Mootz J. M., Voyich J. M., Smeltzer M. S., Bayles K. W., Horswill A. R., Nuclease modulates biofilm formation in community-associated methicillin-resistant Staphylococcus aureus. PLOS ONE 6, e26714 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Tettelin H., Nelson K. E., Paulsen I. T., Eisen J. A., Read T. D., Peterson S., Heidelberg J., De Boy R. T., Haft D. H., Dodson R. J., Durkin A. S., Gwinn M., Kolonay J. F., Nelson W. C., Peterson J. D., Umayam L. A., White O., Salzberg S. L., Lewis M. R., Radune D., Holtzapple E., Khouri H., Wolf A. M., Utterback T. R., Hansen C. L., McDonald L. A., Feldblyum T. V., Angiuoli S., Dickinson T., Hickey E. K., Holt I. E., Loftus B. J., Yang F., Smith H. O., Venter J. C., Dougherty B. A., Morrison D. A., Hollingshead S. K., Fraser C. M., Complete genome sequence of a virulent isolate of Streptococcus pneumoniae. Science 293, 498–506 (2001). [DOI] [PubMed] [Google Scholar]
  • 98.Stover C. K., Pham X. Q., Erwin A. L., Mizoguchi S. D., Warrener P., Hickey M. J., Brinkman F. S. L., Hufnagle W. O., Kowalik D. J., Lagrou M., Garber R. L., Goltry L., Tolentino E., Westbrock-Wadman S., Yuan Y., Brody L. L., Coulter S. N., Folger K. R., Kas A., Larbig K., Lim R., Smith K., Spencer D., Wong G. K.-S., Wu Z., Paulsen I. T., Reizer J., Saier M. H., Hancock R. E. W., Lory S., Olson M. V., Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 406, 959–964 (2000). [DOI] [PubMed] [Google Scholar]
  • 99.Klopfenstein N., Cassat J. E., Monteith A., Miller A., Drury S., Skaar E., Serezani C. H., Murine models for Staphylococcal infection. Curr. Protoc. 1, e52 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Kozlyuk N., Monteith A. J., Garcia V., Damo S. M., Skaar E. P., Chazin W. J., S100 proteins in the innate immune response to pathogens. Methods Mol. Biol. 1929, 275–290 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Figs. S1 to S9


Articles from Science Advances are provided here courtesy of American Association for the Advancement of Science

RESOURCES